Anastomotic device

Information

  • Patent Grant
  • 8262680
  • Patent Number
    8,262,680
  • Date Filed
    Monday, March 10, 2008
    16 years ago
  • Date Issued
    Tuesday, September 11, 2012
    11 years ago
Abstract
An apparatus and system for forming a compression anastomosis. The apparatus includes an anastomotic device with an anastomotic portion including a first end and a second end. The anastomotic portion is formed of a ferrous, magnetic, or paramagnetic material. At least one flexible portion protrudes from the first end of the anastomotic portion. The at least one flexible portion includes an articulation node located at a predetermined distance from the first end of the anastomotic portion. The articulation node enables the at least one flexible portion to move relative to the anastomotic portion. The system further includes a magnet having a first end and a second end. The magnet is adapted to magnetically couple to the anastomotic portion of the anastomotic device and to compress tissue between the magnet and the anastomotic device. The compressive force on the tissue is sufficient to create a compression anastomosis through the tissue.
Description
BACKGROUND

The various embodiments relate generally to surgical devices for forming an anastomosis between organs, and more particularly, to devices that can be inserted through a natural orifice in the body and used to form an anastomosis between various gastrointestinal organs.


Access to the abdominal cavity may be required, from time to time, for diagnostic and therapeutic endeavors for a variety of medical and surgical procedures. Historically, abdominal access has required a formal laparotomy, e.g., abdominal surgery through a surgical incision made in the wall of the abdomen to provide adequate exposure. Such procedures, however, require incisions to be made in the abdomen and may not be particularly well-suited for patients having extensive abdominal scarring from previous procedures, persons who are morbidly obese, individuals with abdominal wall infection, and patients with diminished abdominal wall integrity, such as patients with burns and skin grafting. Other patients simply do not want to have a scar if it can be avoided.


Such conventional open surgical procedures also are employed to address various problems occurring in the gastrointestinal tract, such as the stomach, duodenum, bile duct, jejunum (a portion of the small intestine), colon, ileum, or bowels. Surgical procedures in the gastrointestinal tract are generally performed to treat obese patients, e.g., to decrease absorption of nutrients, and to treat blockages, obstructions, or strictures in the gastrointestinal tact. Blockages, obstructions, or strictures may occur in the duodenum, bile duct, jejunum, or bowels from disease processes such as malignant or benign cancers or tumors and may be treated by using stents or creating an anastomosis between organs in the gastrointestinal tract.


Conventional surgical procedures are employed to insert stents within a blocked, obstructed, or narrowed viscus to provide palliative relief. The stents are located within the viscus to restore or provide some degree of drainage of fluid through the blocked, obstructed, or narrowed viscus. A limitation of stents is the tendency of occlusion and cholangitis resulting from the development of bacterial biofilm. Plastic stents provide a relatively narrow luminal size and therefore lead to a high occlusion rate. Metal expandable stents, despite having significantly increased patency and longer life than plastic stents, also are prone to occlusion and are extremely expensive. Stents may be located within the bile duct, for example, to provide palliative relief of obstructive jaundice resulting from blockages occurring in the bile duct. Rather than stenting the obstruction, creating a permanent fistula of larger diameter than the bile duct between the bile duct and the duodenum provides greater drainage of bile. Therefore, there is a need to provide a new method and apparatus for forming a biliary duodenal anastomosis. There is also a need for a new method and apparatus for forming a biliary drainage anastomosis by forming a choledochoduodenostomy above the ampulla.


Anastomosis is the joining of luminal structures within the body by way of collateral channels when the natural channels are blocked. Common examples are colonic anastomosis in which two portions of the colon are joined together. The anastomosis may be formed between various organs in the gastrointestinal tract. A gastro-jejunostomy anastomosis may be created between the stomach and the jejunum to treat blockages in the duodenum or for malabsorption, e.g., gastric bypass surgery. An entero-enteral anastomosis may be created for jejuno-jeunal bariatric purposes, a colon to ileum anastomosis may be created for bypassing colorectal cancer, and a biliary duodenal anastomosis may be created between the bile duct and the duodenum above a malignant or benign obstruction in the bile duct. Some anastomoses are created using compression techniques. Certain procedures also may require large openings in the bowel wall. Anastomoses also may be formed using linear staplers and require two large centimeter sized holes to be formed in the patient. Thus, most gastrointestinal anastomoses are created using open surgical procedures requiring the patient to be placed under general anesthesia and large incisions in the abdominal wall. Attendant disadvantages of such open surgical procedures include the necessity for general anesthesia, increased post-operative pain, intra-abdominal adhesions, as well as in-patient hospitalization with associated inconvenience and costs.


Some anastomoses may be created by compression or sutureless techniques. A compression anastomosis is formed by necrotic ischemia caused by the occlusion of the blood supply to the tissue. Compression is applied to the tissue using one or more masses to sandwich the tissue in the target area. One compression anastomosis technique employs a compression button that erodes through the bowel wall over several days because of ischemic necrosis resulting in a leak free anastomosis. Another sutureless compression anastomosis technique employs a bio-fragmentable ring to create an anastomosis in the bowel. This technique compared favorably to sutured and stapled anastomosis. Other anastomoses may be created using flexible endoscopy techniques employing spring compression buttons. Flexible endoscopy anastomosis techniques may employ ultrasonography techniques when access is limited to a single endoscopic lumen. Magnets also have been used to form compression anastomoses when access is possible to both transgastric lumens or by passing a device through the jejunum. Magnetic compression gastroenteric anastomosis may be performed by introducing magnets perorally with endoscopic and fluoroscopic guidance and mated across the gastric and jejunal walls. Compression anastomosis may be formed between bile ducts using magnets following duct stenosis in liver transplant patients. In addition to suffering from the limitations discussed above, current open, laparoscopic, and endoscopic surgical techniques fail to provide a convenient way for inserting a distal mass into the gastrointestinal tract and are generally incapable of applying sufficient mass and force to accomplish a clinically acceptable compression anastomosis.


Therefore, there is a need for an alternative to conventional surgery that eliminates abdominal incisions and incision-related complications to diagnose and treat abdominal pathology. There is a need for a new method and apparatus for forming a compression anastomosis. Also, there is a need for a surgical method and apparatus for forming an anastomosis between luminal structures or organs using a minimally invasive surgical technique. More particularly, there is a need for a surgical apparatus for forming anastomosis between various gastrointestinal organs that can be inserted through a natural orifice in the body using a minimally invasive surgical technique. Further, there is a need for a surgical apparatus that can be introduced into the stomach through the mouth for creating clinically acceptable compression anastomosis between the stomach and the jejunum, the colon and the ileum, and/or the bile duct and the duodenum (e.g., biliary-duodenal anastomosis) using minimally invasive surgical techniques. The foregoing discussion is intended only to illustrate some of the shortcomings present in the field at the time, and should not be taken as a disavowal of claim scope.


SUMMARY

In one embodiment, an apparatus includes an anastomotic portion comprising a first end and a second end. At least one flexible portion protrudes from the first end of the anastomotic portion. The at least one flexible portion comprises a first articulation node located at a predetermined distance from the first end of the anastomotic portion. The articulation node enables the at least one flexible portion to move relative to the anastomotic portion.





FIGURES

The novel features of the various embodiments are set forth with particularity in the appended claims. The various embodiments, however, both as to organization and methods of operation, together with advantages thereof, may best be understood by reference to the following description, taken in conjunction with the accompanying drawings as follows.



FIG. 1 is a diagrammatical view illustrating one embodiment of a minimally invasive surgical device introduced into a natural opening of a patient.



FIG.2 illustrates a partial cross-sectional view of the duodenum, the bile duct, and the pancreatic duct.



FIG. 3 illustrates one embodiment of an apparatus for forming a compression anastomosis.



FIG. 4 is a cross-sectional view of one embodiment of an apparatus for forming a compression anastomosis.



FIG. 5 is an end view of one embodiment of an apparatus for forming a compression anastomosis taken along line 5-5 as shown in FIG. 3.



FIG. 6 illustrates one embodiment of an apparatus for forming a compression anastomosis.



FIG. 7 is a cross-sectional view of one embodiment of an apparatus for forming a compression anastomosis.



FIG. 8 is an end view of one embodiment of an apparatus for forming a compression anastomosis taken along line 8-8 as shown in FIG. 6.



FIG. 9 illustrates one embodiment of a magnetic mass for forming a compression anastomosis.



FIG. 10 is a cross-sectional view of one embodiment of a magnetic mass for forming a compression anastomosis.



FIG. 11 is an end-view of one embodiment of a magnetic mass for forming a compression anastomosis taken along line 11-11 as shown in FIG. 9.



FIG. 12 illustrates one embodiment of a magnetic mass for forming a compression anastomosis.



FIG. 13 is a cross-sectional view of one embodiment of a magnetic mass for forming a compression anastomosis.



FIG. 14 is an end-view of one embodiment of a magnetic mass for forming a compression anastomosis taken along line 14-14 as shown in FIG. 12.



FIG. 15 illustrates a partial cross-sectional view of the duodenum, the bile duct, and the pancreatic duct and the introduction of an endoscope into the target area.



FIG. 16 illustrates a partial cross-sectional view of the duodenum, the bile duct, and the pancreatic duct and the introduction of one embodiment of a collapsible biliary anastomotic device into the bile duct through the distal end of the endoscope via the guide-wire.



FIG. 17 illustrates a partial cross-sectional view of the duodenum, the bile duct, and the pancreatic duct and the introduction of a magnet through the stomach using a pusher and a forward viewing endoscope comprising a flexible shaft.



FIG. 18 illustrates a partial cross-sectional view of the duodenum, the bile duct, and the pancreatic duct and illustrates the introduction of the magnet into the duodenum using the pusher and the forward viewing endoscope comprising the flexible shaft.



FIG. 19 illustrates a partial cross-sectional view of the duodenum, the bile duct, and the pancreatic duct and the magnet aligned and attracted to the anastomotic portion of one embodiment of the anastomotic device.



FIG. 20 illustrates a partial cross-sectional view of the duodenum, the bile duct, and the pancreatic duct and the formation of necrotic ischemia of the compressed region of the wall of the duodenum and the wall of the bile duct.



FIG. 21 illustrates a partial cross-sectional view of the duodenum, the bile duct, the pancreatic duct, and an anastomosis formed between the bile duct and the duodenum and one embodiment of a folded anastomotic device attached to a magnet passing through the anastomosis formed between the bile duct and the duodenum.



FIG. 22 illustrates a partial cross-sectional view of the duodenum, the bile duct, the pancreatic duct, and an anastomosis formed between the bile duct and the duodenum and one embodiment of the anastomotic device with the flexible portions folded and a magnet assembly passing through the duodenum and through the remaining portions of the gastrointestinal tract.



FIG. 23 illustrates one embodiment of a magnet magnetically coupled to an anastomotic portion of one embodiment of an anastomotic compressing the tissue layers of the wall of the duodenum and the wall of the bile duct.



FIG. 24 illustrates the formation of an anastomosis after a few days of compression of the tissue layers of the wall of the duodenum and the wall of the bile duct.



FIG. 25 illustrates a magnet assembly passing through the anastomosis from the bile duct to the duodenum as first and second flexible portions of one embodiment of an anastomotic device fold at articulation nodes from the force exerted on the anastomotic portion of the anastomotic device.



FIG. 26 illustrates first and second flexible portions of one embodiment of an anastomotic device folded and a magnet assembly passing through the anastomosis.





DESCRIPTION

Various embodiments will now be described to provide an overall understanding of the principles of the structure, function, manufacture, and use of the devices and methods disclosed herein. One or more examples of these embodiments are illustrated in the accompanying drawings. Those of ordinary skill in the art will understand that the devices and methods specifically described herein and illustrated in the accompanying drawings are non-limiting embodiments and that the scope of the various embodiments is defined solely by the claims. The features illustrated or described in connection with one embodiment may be combined with the features of other embodiments. Such modifications and variations are intended to be included within the scope of the claims.


It will be appreciated that the terms “proximal” and “distal” are used herein with reference to a clinician manipulating an end of an instrument that protrudes out of the mouth of the patient. The term “proximal” refers to the portion closest to the surgeon and the term “distal” refers to the portion located away from the surgeon. It will be further appreciated that for conciseness and clarity, spatial terms such as “vertical,” “horizontal,” “up,” and “down” may be used herein with respect to the drawings. However, surgical instruments are used in many orientations and positions, and these terms are not intended to be limiting and absolute.


The various embodiments generally provide methods and devices for creating anastomosis at various sites, e.g., target areas or tissue treatment regions, in the gastrointestinal tract. The devices may be introduced via natural orifices and may be combined with trans-organ techniques. In one embodiment, a Natural Orifice Translumenal Endoscopic Surgery (NOTES)™ techniques may be employed to introduce instruments into the patient and carry out the various procedures described hereinbelow. A NOTES™ technique is a minimally invasive therapeutic procedure that may be employed to treat diseased tissue through a natural opening of the patient without making incisions in the abdomen. A natural opening may be the mouth, anus, and/or vagina. Medical implantable instruments may be introduced into the patient to the target area via the natural opening. In a NOTES™ technique, a surgeon inserts a flexible endoscope into one or more natural openings of the patient to view the target area using a camera. During endoscopic surgery the surgeon inserts surgical devices through one or more lumens or working channels of the endoscope to perform various key surgical activities (KSA). These KSAs include forming an anastomosis between organs, and more particularly, forming anastomosis between gastrointestinal organs with devices that can be inserted through a natural opening of the body.


Although various embodiments described herein refer to for creating an anastomosis between the duodenum and the bile duct by accessing those organs through the mouth and esophagus of a patient, those of ordinary skill in the art will readily appreciate that unique and novel aspects of the various embodiments could be successfully employed in connection with forming anastomosis between other organs by gaining access thereto through other natural openings such as the anus, or the vagina, for example, without departing from the scope of the appended claims.



FIG. 1 is a diagrammatical view illustrating one embodiment of a minimally invasive surgical device introduced into a natural opening of a patient. In the illustrated embodiment, an endoscope 10 comprising a flexible shaft 12 is introduced into the mouth 14, though the esophagus 16, and into the stomach 18 of a patient 8. The flexible shaft 12 may be passed through a per-oral overtube (a plastic tube of varying length) to protect the esophagus 16 when the flexible shaft 12 of the endoscope 10 is introduced into the patient 8. From the stomach 18, a distal end 26 of the flexible shaft 12 of the endoscope 10 is inserted in the duodenum 20. From the duodenum 20, an anastomotic device may be introduced into a portion of the biliary tree 22 through the sphincter of Oddy ampullary opening 28. In one embodiment, the endoscope 10 may be a side-viewing or front-viewing endoscope. In one embodiment, the endoscope 10 could be used in an endoscopic retrograde cholangio-pancreatography (ERCP) technique to access and image the bile duct 24 endoscopically. In an ERCP technique, a catheter is introduced through the opening 28 of the bile duct 24 from the duodenum 20 via a working channel of a side-viewing flexible ERCP endoscope 10 under X-Ray or fluoroscopic guidance.



FIG. 2 illustrates a partial cross-sectional view of the duodenum 20, the bile duct 24, and the pancreatic duct 30. The biliary tree 22 connects the gall bladder 21 and the liver (not shown) to the duodenum 20 through the opening 28. The bile duct 24 and the pancreatic duct 30 enter the descending duodenum 20, commonly known together as the hepatopancreatic duct (or pancreatic duct), through the major duodenal papilla 29 and the common orifice 28. The bile duct 24 and the pancreatic duct 30 are in fluid communication with the duodenum 20 through the common opening 28. An anastomotic device may be introduced into the bile duct 24 through the opening 28 after cannulation of the bile duct 24 with the distal end 26 of the endoscope 10. Biliary cannulation and placement of an anastomotic device may be accomplished with both standard forward viewing and side-viewing endoscopes, for example.



FIGS. 3-5 illustrate one embodiment of an apparatus for forming a compression anastomosis. In the illustrated embodiment, an anastomotic device 32 comprises a general longitudinal tubular structure suitable for positioning within a hollow viscus to drain fluid through a central lumen to palliate an obstruction within the hollow viscus. The anastomotic device 32 may be introduced into a hollow viscus using a flexible endoscope over a guide-wire and can be pushed into position with a catheter or pusher tube. In one embodiment, the anastomotic device 32 is shaped like a thin flexible catheter that can be inserted into the hollow viscus requiring anastomosis. The positioning of the anastomotic device 32 may be conducted under direct vision with an endoscope. The anastomotic device 32 may be introduced into the hollow viscus of the bile duct 24 through the opening 28 after the bile duct 24 is cannulated with the distal end 26 of the endoscope 10. Once positioned in the bile duct 24, the anastomotic device 32 performs the function of a biliary stent to palliate a blockage, obstruction, or stricture in the bile duct 24. The anastomotic device 32 also comprises articulation nodes that enable flexible portions of the anastomotic device 32 to move relative to other more rigid portions of the anastomotic device 32. When the flexible portions of the anastomotic device 32 are in flexion, the anastomotic device 32 can pass through the anastomosis once it is formed.


In one embodiment, the anastomotic device 32 comprises a first portion 36 having a first and second end. In one embodiment, at least a first flexible portion 38a protrudes from one end. In another embodiment, the anastomotic device 32 may comprise a second flexible portion 38b protruding from the other end. The first portion 36 is generally substantially rigid relative to the first and second flexible portions 38a, b, although in some embodiments, the first portion 36 may be formed of flexible materials. In one embodiment, the first and second flexible portions 38a, b may be fastened, linked, associate together, joined, connected, or attached to the first portion 36. In another embodiment, the first and second flexible portions 38a, b may be formed integrally with the first portion 36 as a continuous component. For conciseness and clarity, the first portion 36 is referred to herein as the anastomotic portion 36. The anastomotic portion 36 comprises an anastomotic surface, which is defined as the portion of the anastomotic device 32 that contacts one side of the tissue to be anastomosed. In the illustrated embodiment, the anastomotic portion 36 is in fluid communication with the first flexible portion 38a on one end and is in fluid communication with the second flexible portion 38b on the other end. In other words, in one embodiment, the anastomotic portion 36 is located between the first and second flexible portions 38a, b and the three portions are in fluid communication by way of a central lumen 34 for conducting fluid. In the illustrated embodiment, the anastomotic portion 36 and the first and second flexible portions 38a, b have a generally cylindrical form with the central lumen 34 fluidically coupling the three portions to conduct fluid therethrough. In one embodiment, the central lumen 34 may be eliminated and the anastomotic device 32 may be comprised of a solid material. This embodiment may be employed in applications that do not require fluid to be drained through the anastomotic device 32.


In one embodiment, the anastomotic portion 36 may be formed of any one of a ferrous, magnetic, or paramagnetic material. It will be appreciated by those skilled in the art that paramagnetism is a form of magnetism which occurs only in the presence of an externally applied magnetic field. Accordingly, paramagnetic materials are attracted to magnetic fields, and hence have a relative magnetic permeability greater than one (or, equivalently, a positive magnetic susceptibility). In other embodiments, the anastomotic portion 36 may comprise magnets or magnetic material attached thereto. In other embodiments, the anastomotic portion 36 may be formed of non-ferrous material having magnets formed integral therewith or attached thereto. In various other embodiments, the anastomotic portion 36 may be formed of ferrous, magnetic, or paramagnetic material. In various embodiments, the anastomotic portion 36 may be formed of quaternary Iron, Neodymium, Iron, Boron, and/or Samarium materials. In one embodiment, the anastomotic portion 36 may be encased in a protective plastic. In one embodiment, the anastomotic portion 36 may comprise a coating such as plated Chromium. In one embodiment, the first portion 36 also may be formed of rubber plastic magnetic strips which may be flexible. In various embodiments, the rubber magnetic strips may be formed by incorporating Neodymium, Iron, and/or Boron particles in a rubber or plastic material.


In one embodiment, the first and second flexible portions 38a, b are formed of flexible tubular plastic material. The plastic tubes may be formed of a polymeric material such as polyethylene. The first and second flexible portions 38a, b may be tapered or untapered. In one embodiment, the flexible portions 38a, b may be tapered towards the free end to aid introduction of the anastomotic device 32 into the hollow viscus. In one embodiment, a conical element may be attached to either one or both of the first and second plastic portions 38a, b to assist introduction of the anastomotic device 32 in a narrow opening. The conical element may comprise a lumen to conduct fluid therethrough. In one embodiment, the first and second flexible portions 38a, b may be hollow plastic tubes or may be a solid material.


Each of the first and second flexible portions 38a, b comprise articulation nodes 40a, b situated at some distance from either end of the anastomotic portion 36. Each of the articulation nodes 40a, b forms a movable joint between the anastomotic portion 36 and each of the flexible portions 38a, b. One or both of the flexible portions 38a, b may comprise the articulation nodes 40a, b to enable the flexible portions 38a, b of the anastomotic device 32 to move relative to the anastomotic portion 36 and allowing a limited angle of rotation between the anastomotic portion 36 and the flexible portions 38a, b. The articulation nodes 40a, b enable the flexible portions 38a, b to move (e.g., flex, rotate over a limited angle, fold, bend, buckle, collapse, deform, or otherwise change shape) relative to the anastomotic portion 36. For example, the articulation nodes 40a, b enable the flexible portions 38a, b to move from a continuous longitudinally extending tube to a “U-shaped” tube. In flexion, the anastomotic device 32 can fall through the anastomosis. In the illustrated embodiment, the articulation nodes 40a, b are formed as weaknesses on the flexible portions 38a, b. The substantially elongated tubular first and second flexible portions 38a, b bend, collapse, or deform at the articulation nodes 40a, b when the anastomotic portion 36 is magnetically coupled to a larger mass to enable the anastomotic device 32 to fall through a mature anastomosis toward the side having a larger mass. In the embodiments illustrated in FIGS. 15-26, for example, the articulation nodes 40a, b form a collapsible biliary anastomotic device 32 to create a compression anastomosis between the biliary tree 22 and the duodenum 20. The first and second flexible portions 38a, b begin to move as the anastomosis matures and the anastomotic portion 36 is magnetically attracted to a larger mass and falls through the compression anastomosis leaving a fistula above the papilla 29. In other embodiments, the articulation nodes 40a, b may be formed such that the flexible portions 38a, b fall apart or release from the anastomotic portion 36 after the anastomotic device 32 is positioned within the hollow viscus, e.g., the bile duct 24.


In the illustrated embodiment, the central lumen 34 extends along a longitudinal axis A. The central lumen 34 is suitable for conducting fluid within the hollow viscus during the period required for the translumenal anastomosis to mature. For example, in one application, the anastomotic device 32 may be positioned in the bile duct 24 across an area of obstruction to form a biliary duodenal anastomosis. While the anastomosis matures (generally a few days), the central lumen 34 drains bile from the bile duct 24 to the duodenum 20.


The anastomotic device 32 also may comprise serrations to retain the anastomotic device 32 positioned within the hollow viscus to minimize the opportunity of the anastomotic device 32 falling out of the hollow viscus. The serrations also may serve to control how far the anastomotic device 32 can be introduced into the hollow viscus. In one embodiment, the anastomotic device 32 may comprise a proximal thread, which can be grasped with a clamp-like end effect or introduced through the working channel of the endoscope 10, to retract the anastomotic device 32 in case it is pushed too far within the hollow viscus.



FIGS. 6-8 illustrate one embodiment of a surgical instrument for forming a compression anastomosis. In the illustrated embodiment, an anastomotic device 42 comprises at least one anastomotic portion 46 and the at least one flexible portion 38a. The anastomotic portion 46 may be formed of ferrous or non-ferrous materials and may comprise at least one magnet 48 attached thereto. In the illustrated embodiment, the anastomotic portion 46 comprises a plurality of magnets 48 and is sandwiched between the first and second flexible portions 38a, b as described above with reference to FIGS. 3-5. In one embodiment, the magnets 48 may be discrete magnets embedded and spaced apart in plastic to allow the anastomotic portion 46 to bend to a certain degree. In various embodiments, the anastomotic portion 46 also may be formed of magnetic flexible rubber plastic strips, which may be formed by incorporating Neodymium, Iron, and/or Boron particles in a rubber or plastic material.


In various embodiments, the anastomotic devices 32, 42 may comprise a guide-wire running through the central lumen 34, a second lumen formed through the body portions of the anastomotic devices 32, 42 (e.g., the anastomotic portion 36, the anastomotic portion 46, and the first and second portions 38a, b), or in a tract along the outside the anastomotic devices 32, 42. In one embodiment, the anastomotic devices 32, 42 also may comprise a guide-wire along a portion of its length exiting on the side in a monorail configuration. In one embodiment, the ends of the anastomotic devices 32, 42 may be straight or curled (pigtail) in shape. In one embodiment the anastomotic device 32, 42 also could be impregnated with a drug, for example a chemotherapeutic drug, which could be placed in an obstructed viscus, e.g., a bile duct obstructed from biliary or pancreatic cancer, and deliver treatment to the tumor for several days while the anastomosis is forming. In one embodiment, the anastomotic devices 32, 42 also could be radioactive and be used for treating the tumors of the gastrointestinal tract. In one embodiment, the anastomotic devices 32, 42 also could be biodegradable and reduce the possibility of the magnet and/or anastomotic device 32, 42 assembly getting stuck in the gastrointestinal tract.


In one embodiment, the anastomotic device 32, 42 may be placed across a tumor and magnetic “seeds” embedded with a chemotherapeutic or radioactive material may be employed to deliver drug or radiation to the tumor. A magnet 50, 60 (FIGS. 9-14) may be subsequently located in the stomach 18 or bowel to form an anastomosis.


The anastomotic devices 32, 42 may be employed in combination with an external mass, e.g., magnets 50, 60 (FIGS. 9-14), to form a compression anastomosis at a wide range of target areas. The combination of the anastomotic device 32, 42 and the magnet 50, 60 is referred to herein as a magnet assembly 86 (FIGS. 20-26). In the embodiment illustrated in FIGS. 21, 22, and 24-26, an anastomosis 84 is formed by coupling the anastomotic device 42 with the magnet 50 to compress tissue above the ampullary opening 28 between the duodenum 20 and the bile duct 24. In one embodiment, the combination of the anastomotic device 32, 42 and the magnet 50, 60, e.g., the magnet assembly 86, may be employed to form anastomosis using a variety of surgical techniques including, for example, a NOTES™ procedure, a laparoscopy, a or laparotomy. The types of anastomosis that may be formed using the magnet assembly 86 comprised of any combination of the anastomotic devices 32, 42 and the magnets 50, 60 include entero-enteral anastomoses to treat blockages in the bile duct, jejuno-jeunal anastomoses for bariatric purposes, and/or colon to ileum anastomoses for bypassing colorectal cancer, among others. The magnet assembly 86 also may be employed to form biliary duodenal anastomoses between the bile duct 24 and the duodenum 20 above malignant or benign obstructions. The magnet assembly 86 can form anastomoses with a diameter that is much larger than the diameter of a conventional stent. A compression anastomosis formed of epithelialized tissue is not likely to result in a biofilm blockage, which is likely to occur with most conventional stents within a few weeks and thus will require replacement. In other embodiments, the magnet assembly 86 may be employed to form compression anastomoses without making large holes in the intestine. For example, the magnet assembly 86 may be employed to form two holes in the bowel that may be less than 3 mm in diameter. The magnet assembly 86 can be used with flexible instruments to form entero-enteral anastomosis having a length of about 3 mm to about 10 mm.


The magnetic compression magnet assembly 86 (FIGS. 20-26) also may be used to form anastomoses using an intralumenal endoscope (or radiological) to access the lumen of a first limb of an anastomosis and transgastric gastroscope to access the lumen of a second of the limb of the anastomosis. This may be accomplished by inserting the intralumenal endoscope in the rectum to access the first limb and inserting the transgastric gastroscope into the small intestine through a very small incision (e.g., keyhole, pinhole) and then pushing the gastroscope inside the intestine to connect with magnets held by the intralumenal endoscope. The magnet assembly 86 can be used with flexible instruments to form entero-enteral anastomosis using a double channel endoscope in a NOTES™ procedure.



FIGS. 9-11 illustrate one embodiment of a magnetic mass for forming a compression anastomosis. Employing a minimally invasive surgical technique, e.g., a NOTES™ procedure, the magnet 50 is introduced into a hollow organ or lumen adjacent to the target area where the anastomosis is to be formed. In one embodiment, the magnet 50 may be introduced into the lumen using an endoscope. In one embodiment, the magnet 50 is placed in the duodenum 20, for example, to work in conjunction with either one of the anastomotic device 32, 42 to form a biliary duodenal compression anastomosis. The magnet 50 is generally cylindrical in shape and may comprise a longitudinal lumen or opening 52. A guide-wire engages the opening 52 to locate the magnet 50 in the target area, e.g., the duodenum 20. In the embodiment illustrated in FIGS. 9-11, the opening 52 is offset from the central axis B. In the embodiment illustrated in FIGS. 12-14, the opening 52 may be centered about a central axis B. In one embodiment, the shape of the magnet 50 or its casing is capsular with radii 54, 56 formed on either end thereof. The rounded capsular geometry enables safe passage of the magnet 50 through the gastrointestinal tract. In one embodiment, the radii 54, 56 may have a substantially equal radius. In one embodiment, the magnet 50 may comprise a coating 65 such as plastic or plated in Chromium to resist corrosion in the body. The magnet 50 may be formed of Neodymium, Iron, Boron, and/or Samarium materials.


The strength of the magnet 50 should be sufficient to exert an attractive magnetic force to the anastomotic portion 36, 46 across the thickness of the tissue to be anastomosed. As an example, the tissue of the small intestine or colon is approximately 1 mm to 1.5 mm. Thus, in forming an anastomosis between the small intestine and the colon, the strength of the magnet 50 should be sufficient to exert an attractive magnetic force across tissue having a thickness of about 2 mm to about 3 mm. The strength of the magnet 50 should be suitable to exert a sufficient compressive force to tissue positioned (e.g., sandwiched) between the magnet 50 and the anastomotic portion 36, 46 to cause ischemic necrosis of the tissue. The compressive force generated by the magnetic attractive force on the tissue sandwiched between the magnet 50 and the anastomotic portion 36, 46 should be adequate to cause ischemic necrosis, fistulization, and the formation of an anastomosis therethrough. In one embodiment, the tissue compressed between the magnet 50 and the anastomotic portion 36, 46 may be a wall 58 of the bile duct 24 and a wall 68 of the duodenum 20 located just above the papilla 29 (FIGS. 15-26).


The polarities of the magnet 50 and the anastomotic portion 36, 46 should be oriented to create a suitable attractive magnetic force therebetween. In one embodiment, the anastomotic portion 36 and/or the magnet 50 may have markings indicative of the magnetic poles formed thereon to assist the user orient the devices. The magnet 50 and the anastomotic portion 36, 46 should be oriented to create a suitable attractive force between the magnet 50 and the anastomotic portion 36, 46 to line up and attract along the length of the desired anastomosis.


With reference now also to FIGS. 2-5, length of the magnet 50 should correspond substantially to the length of the anastomotic portion 36, 46 such that a suitable magnetic field develops therebetween to couple the two components substantially along the length of the anastomotic portion 36, 46 and the magnet 50. In one embodiment, the length of the magnet 50 may be the same as the length of the anastomotic portion 36, 46. In one embodiment, the magnet 50 and the anastomotic portion 36, 46 may be substantially similar.


In one embodiment, the magnet 50 may be formed as a single magnetic component. In other embodiments, the magnet 50 may comprise a stack of two or more hollow magnets preferably with a flexible tapered introducer. In one embodiment, the magnet 50 may be asymmetrical comprising more massive portions on a particular side to bias the way the combination of the magnet 50 and the anastomotic device 32, 42 falls through the anastomosis. For example, with the anastomotic device 32 located in the bile duct 24, it would be preferable to locate the more massive magnet 50 in the duodenum 20 to bias the anastomotic device 32 and urge it to pass from the wall 58 of the bile duct 24 through the wall 68 of the duodenum 20 and into jejunum and further into the small intestine. If a small intestinal colonic anastomosis is desired, it would be preferable to locate the anastomotic device 32, 42 in the small intestine and to locate a more massive magnet 50 in the colon.


As shown in FIGS. 17-26, once the anastomosis 84 has matured, the magnet assembly 86 falls into the duodenum 20. The magnetic force between the magnet 50 and the anastomotic portion 46 in combination with the peristaltic force (the squeezing propulsive force from the walls of the duodenum) is sufficient to pull the anastomotic device 42 through the wall 58 of the bile duct 24 and the wall 68 of the duodenum 20. As the magnet assembly 86 falls through the anastomosis 84 into the duodenum 20, the first and second flexible portions 38a, b of the anastomotic device 42 move to enable the magnet assembly 86 to pass through the anastomosis 84 and into the duodenum 20. Subsequently, the magnet assembly 86 is passed through the gastrointestinal tract and exits the body through the anus typically within 72 hours to a week later.



FIGS. 12-14 illustrate one embodiment of a magnetic mass for forming a compression anastomosis. The magnet 60 can be positioned in the target area employing a minimally invasive technique. In combination with the anastomotic device 32, 42 described above the magnet 60 is used to form a compressive anastomosis. The magnet 60 is generally cylindrical in shape and may comprise a longitudinal lumen or opening 52 centered about a central axis B. The magnet 60 also may comprise a tube 62 attached thereto. The tube 62 comprises an opening 63 for receiving a guide-wire therethrough to position the magnet 60 in the target area, e.g., the duodenum 20. The shape of the magnet 60 or its casing will be preferably capsular with radii 64, 66 formed on either end thereof to enable safe passage of the magnet 60 through the gastrointestinal tract. In one embodiment, the radii 64, 66 may have a substantially equal radius. In one embodiment, the magnet 60 may comprise a coating 65 such as plastic or plated Chromium to resist corrosion in the body. The magnet 60 may be formed of Neodymium, Iron, Boron, and/or Samarium materials.


The anastomosis 84 (FIGS. 21-26) may have a length ranging from about 5 mm to about 10 mm, although greater or shorter lengths may be desired and may be obtainable by controlling the length of the anastomotic device 32, 42 and the magnet 50, 60. For example, the length of the anastomosis 84 may be determined based on the length of the magnet 50, 60 relative to the anastomotic portion 36, 46 or may be determined based on the length of the anastomotic portion 36, 46 relative to the magnet 50, 60. The length of the anastomosis 84 also may be determined by the number of the magnets 48 on the anastomotic portion 46 of the anastomotic device 42. Either the length of the magnet 50, 60 or the length of the anastomotic portion 36, 46 may be adjusted to obtain an anastomosis 84 of a suitable length. Accordingly, anastomoses having lengths similar to those achievable with linear staplers may be achieved by adjusting the lengths of the magnet 50, 60 and/or the corresponding anastomotic portions 36, 46.



FIGS. 15-22 illustrate one embodiment of a minimally invasive endoscopic method of forming a compression anastomosis. FIGS. 23-26 illustrate the anastomosis formation process in more detail. In one embodiment, the minimally invasive endoscopic method may be a NOTES™ procedure. In the method illustrated in FIGS. 15-26, the anastomosis 84 is formed between the bile duct 24 and the duodenum 20 using the magnet 50 and the collapsible biliary anastomotic device 42 previously described with reference to FIGS. 6-11. The illustrated method is a technique for forming a biliary drainage anastomosis by forming a choledochoduodenostomy above the ampulla using one embodiment of the anastomotic device 42 and the magnet 50. This procedure may be employed to treat selected patients with retained, recurrent, and impacted bile duct stones; strictures of the bile ducts; stenosis of the sphincter of Oddi; pancreatitis associated with biliary disease; choledochal cysts; fistulas of the bile duct; and biliary obstruction, either benign or malignant, for example. The illustrated method for forming a compression anastomosis 84 provides several advantages over standard biliary stenting techniques. A choledochoduodenostomy may be formed by appropriately positioning the anastomotic device 42 and the magnet 50. The size of the choledochoduodenostomy may range from approximately 1 cm to approximately 3 cm and may be determined by the length of the anastomotic portion 46 and the magnet 50. A compression anastomosis 84 is formed by ischemic necrosis through tissue compressed between the anastomostic device 42 and the magnet 50 when they are magnetically coupled. The articulation nodes 40a, b enable the flexible portions 38a, b to collapse and allow the magnetically coupled anastomotic device 42 and the magnet 50, e.g., magnet assembly 86, to fall through the compression anastomosis 84 and subsequently is excreted through the gastrointestinal tract. The anastomotic device 42 decreases the likelihood of prosthetic material being left in the bile duct 24 with subsequent biofilm build up. The anastomosis 84 formed using the illustrated method provides an essentially leak free anastomosis. Placement of the anastomotic device 42 in the bile duct 24 enables biliary drainage through the central lumen 34 during the formation of the anastomosis 84. The transpapillary drainage during this period serves to minimize any untoward (e.g., unfavorable) effects from minor anastomotic leaks, for example.



FIG. 15 illustrates the introduction of an endoscope into the target area. In the illustrated embodiment, the endoscope 10 is a side viewing endoscope and is inserted in the duodenum 20. The distal end 26 of the flexible shaft 12 of the endoscope 10 is introduced into the duodenum 20 in an area adjacent to the ampullary opening 28 opposite the bile duct 24.



FIG. 16 illustrates the introduction of one embodiment of a collapsible biliary anastomotic device 42 into the bile duct 24 through the distal end 26 of the endoscope 10 via a guide-wire 70. In other embodiments, the anastomotic device 42 may be delivered to the target area translumenally. The anastomotic device 42 is positioned in the bile duct 24 endoscopically through the flexible shaft 12 of the endoscope 10 over the guide-wire 70. The bile duct 24 is cannulated using the distal end 26 of the endoscope 10. The anastomotic device 42 is inserted into the bile duct 24 through the ampullary opening 28 of the papilla 29 in the duodenum 20 after the bile duct 24 has been cannulated with the distal end 26 of the endoscope 10. The guide-wire 70 is then inserted into the bile duct 24. The anastomotic device 42 is inserted over the guide-wire 70 and a pusher tube is used to position the anastomotic device 42 into the bile duct 24 under direct vision. This procedure may be conducted using an ERCP endoscope or any suitable viewing endoscope. The anastomotic device 42 may be positioned into the bile duct 24 over the guide-wire 70 in a straight configuration. The flexible portions 38a, b of on either side of the articulation nodes 40a, b facilitate the positioning of the anastomotic device 32 over the guide-wire 70 into the bile duct 24. In the illustrated method, one end 72a of the anastomotic device 42 is located in the dilated ampullary opening 28 and the other end 72b of the anastomotic device 42 is located within the bile duct 24. Once the anastomotic device 42 is positioned in the bile duct 24, its position can be checked using fluoroscopy (X-Rays) and subsequently the guide-wire 70 is withdrawn.


As previously stated, once positioned within the bile duct 24, the anastomotic device 42 allows passage of bile through the dilated ampullary opening 28 into the duodenum 20 until the anastomosis 84 matures. Bile from the liver (not shown) or the gall bladder 21 flows through the central lumen 34 of the anastomotic device 42 past an obstruction in the bile and into the duodenum 20 to relieve the patient of jaundice. The flexible portions 38a, bmove to allow the anastomotic device 42 to fall through the anastomosis into the duodenum 20.



FIG. 17 illustrates the introduction of the magnet 50 through the stomach 18 using a pusher 82 and a forward viewing endoscope 100 comprising a flexible shaft 80. FIG. 18 illustrates the introduction of the magnet 50 into the duodenum 20 using the pusher 82 and the forward viewing endoscope 100 comprising the flexible shaft 80. With reference to FIGS. 17 and 18, the pusher 82 may be a catheter or piece of tubing for pushing the magnet 50 ahead using the forward looking endoscope 100. The flexible shaft 80 may be passed through a per-oral overtube, for example, to protect the esophagus. The magnet 50 is pushed along the gastrointestinal tract with the pusher 82 until it is positioned within the duodenum 20 near the ampullary opening 28. Within the duodenum 20, the magnet 50 is manipulated and aligned so as to be properly oriented to attract the anastomotic portion 46 of the anastomotic device 42 previously positioned in the bile duct 24. When properly aligned, the wall 68 of the duodenum 20 and the wall 58 of the bile duct 24 are compressed (e.g., sandwiched) between the magnet 50 and the anastomotic portion 46 of the anastomotic device 42. The flexible shaft 80 and the pusher 82 are withdrawn when the magnet 50 is magnetically coupled to the anastomotic device 42.



FIG. 19 illustrates the magnet 50 aligned and attracted to the anastomotic portion 46 of the anastomotic device 42. The wall 68 of the duodenum 20 and the wall 58 of the bile duct 24 are compressed between the magnet 50 and the anastomotic portion 46 of the anastomotic device 42.



FIG. 20 illustrates the formation of necrotic ischemia of the compressed region of the wall 68 of the duodenum 20 and the wall 58 of the bile duct 24. A compression anastomosis 84 is formed between the duodenum 20 and the bile duct 24 after a period of time. The magnetic attractive force exerted by the relatively more massive magnet 50 attracts the anastomotic portion 46. This action tends to move the flexible portion 38a, b of the anastomotic device 42 at the articulation nodes 40a, b as the anastomotic device 42 erodes through the compressed tissue. As previously discussed, the peristaltic force also assist the magnet assembly 86 to eventually fall through the mature anastomosis 84 into the duodenum 20.



FIGS. 21-22 illustrate the formation of the compression anastomosis 84 and the magnet assembly 86 passing through the anastomosis 84 into the duodenum 20 and the remaining portions of the gastrointestinal tract. The compression anastomosis 84 is formed by necrotic ischemia caused by the occlusion of blood supply to the tissue (e.g., the wall 68 of the duodenum 20 and the wall 58 of the bile duct 24) compressed between the magnet 50 and the anastomotic portion 46 of the anastomotic device 42. Once the compression anastomosis 84 is formed between the bile duct 24 and the duodenum 20, the more massive magnet 50 attracts the anastomotic device 42 through the anastomosis 84 into the duodenum 20. The flexible portions 38a, b of the anastomotic device 42 move at the respective articulation nodes 40a, b to enable the anastomotic device 42 to fit through the anastomosis 84 and pass into the duodenum 20. FIG. 21 illustrates one embodiment of the folded anastomotic device 42 attached to the magnet 50 (e.g., magnet assembly 86) passing through the anastomosis 84 formed between the bile duct 24 and the duodenum 20. FIG. 22 illustrates one embodiment of the anastomotic device 42 with the flexible portions 38a, b folded and the magnet assembly 86 passing through the duodenum 20 and through the remaining portions of the gastrointestinal tract. Within a few days the magnet assembly 86 passes through the gastrointestinal tract and exits the body from the anus. A typical period for passing the magnet assembly 86 is about 72 hours to about a week after the anastomosis 84 matures.



FIGS. 23-26 illustrate the formation of the compression anastomosis 84 and the magnet assembly 86 passing through the anastomosis 84 into the duodenum 20. FIG. 23 illustrates the magnet 50 magnetically coupled to the anastomotic portion 46 of the anastomotic 42 compressing the tissue layers of the wall 68 of the duodenum 20 and the wall 58 of the bile duct 24. FIG. 24 illustrates the formation of the anastomosis 84 after a few days of compression of the tissue layers of the wall 68 of the duodenum 20 and the wall 58 of the bile duct 24. As previously discussed, the anastomosis 84 is formed by ischemic necrosis as a result of compression between the magnet 50 and the anastomotic device 42. Also, once the anastomosis 84 is formed the magnet 50 and the anastomotic device 42 are directly coupled and form the magnet assembly 86. FIG. 25 illustrates the magnet assembly 86 passing through the anastomosis 84 from the bile duct 24 to the duodenum 20 as the first and second flexible portions 38a, b of one embodiment of the anastomotic device 42 fold at the articulation nodes 40a, b from the force exerted on the anastomotic portion 46 of the anastomotic device 42. The force exerted on the anastomotic device 42 may include the magnetic attractive force exerted by the magnet 50 as well as the peristaltic force, e.g., the squeezing propulsive force from the walls 68 of the duodenum 20. FIG. 26 illustrates the first and second flexible portions 38a, b of one embodiment of the anastomotic device 42 folded and the magnet assembly 86 passing through the anastomosis 84.


In one embodiment, in a NOTES™ procedure an entero-enteral anastomosis may be formed by inserting the anastomotic device 32, 42 and magnet the 50, 60 to the target area using a translumenal double channel gastroscope. A TAS device may be employed to hold two loops of bowel together. A grasper holds one side of the bowel and a needle knife penetrates the small intestine with passage of a guide-wire. The anastomotic device 32, 42 can be pushed through into the small intestine through a hole of only 7F in size with a pusher. Subsequently the guide-wire and the pusher are withdrawn. The process may be repeated on the other side of the bowel to insert the magnet 50. Slightly bigger holes may be required to properly insert the anastomotic device 32, 42 and the magnet 50, 60. The small holes may be closed with clips or stitches.


While several embodiments have been illustrated and described, and while several illustrative embodiments have been described in considerable detail, the embodiments are not intended to restrict or in any way limit the scope of the appended claims to such detail. Additional advantages and modifications may readily appear to those skilled in the art. Those of ordinary skill in the art will readily appreciate the different advantages provided by these various embodiments. While the various surgical instruments have been herein described in connection with the formation of an entero-enteral anastomosis through the mouth, those of ordinary skill in the art will readily appreciate that the unique and novel features of the various embodiments may be effectively employed in connection with forming an anastomosis between other organs which may be accessed through other natural orifices in the patient. In addition, it is conceivable that the various embodiments could have utility in some laparoscopic surgical procedures and therapies.


While several embodiments have been described, it should be apparent, however, that various modifications, alterations and adaptations to those embodiments may occur to persons skilled in the art with the attainment of some or all of the advantages of the embodiments. For example, according to various embodiments, a single component may be replaced by multiple components, and multiple components may be replaced by a single component, to perform a given function or functions. This application is therefore intended to cover all such modifications, alterations and adaptations without departing from the scope of the appended claims.


The devices disclosed herein can be designed to be disposed of after a single use, or they can be designed to be used multiple times. In either case, however, the device can be reconditioned for reuse after at least one use. Reconditioning can include a combination of the steps of disassembly of the device, followed by cleaning or replacement of particular pieces, and subsequent reassembly. In particular, the device can be disassembled, and any number of particular pieces or parts of the device can be selectively replaced or removed in any combination. Upon cleaning and/or replacement of particular parts, the device can be reassembled for subsequent use either at a reconditioning facility, or by a surgical team immediately prior to a surgical procedure. Those of ordinary skill in the art will appreciate that the reconditioning of a device can utilize a variety of different techniques for disassembly, cleaning/replacement, and reassembly. Use of such techniques, and the resulting reconditioned device, are all within the scope of the present application.


Preferably, the embodiments described herein will be processed before surgery. First a new or used instrument is obtained and, if necessary, cleaned. The instrument can then be sterilized. In one sterilization technique, the instrument is placed in a closed and sealed container, such as a plastic or TYVEK® bag. The container and instrument are then placed in a field of radiation that can penetrate the container, such as gamma radiation, x-rays, or higher energy electrons. The radiation kills bacteria on the instrument and in the container. The sterilized instrument can then be stored in the sterile container. The sealed container keeps the instrument sterile until it is opened in the medical facility.


Any patent, publication, or other disclosure material, in whole or in part, that is said to be incorporated by reference herein is incorporated herein only to the extent that the incorporated materials does not conflict with existing definitions, statements, or other disclosure material set forth in this disclosure. As such, and to the extent necessary, the disclosure as explicitly set forth herein supersedes any conflicting material incorporated herein by reference. Any material, or portion thereof, that is said to be incorporated by reference herein, but which conflicts with existing definitions, statements, or other disclosure material set forth herein will only be incorporated to the extent that no conflict arises between that incorporated material and the existing disclosure material.


The embodiments are not to be construed as limited to the particular embodiments disclosed. The embodiments are therefore to be regarded as illustrative rather than restrictive. Variations and changes may be made by others without departing from the scope of the claims. Accordingly, it is expressly intended that all such equivalents, variations and changes that fall within the scope of the claims be embraced thereby.


In summary, numerous benefits have been described which result from employing the concepts described herein. The foregoing description of the one or more embodiments has been presented for purposes of illustration and description. It is not intended to be exhaustive or limiting to the precise form disclosed. Modifications or variations are possible in light of the above teachings. The one or more embodiments were chosen and described in order to illustrate principles and practical application to thereby enable one of ordinary skill in the art to utilize the various embodiments and with various modifications as are suited to the particular use contemplated. It is intended that the claims submitted herewith define the overall scope.

Claims
  • 1. An apparatus for forming an anastomosis by compressing tissue between a magnet and a surface of an anastomotic portion wherein the apparatus is configurable between an extended state to form the anastomosis and a collapsed state to pass through the anastomosis, the apparatus comprising: an anastomotic portion extending along a longitudinal axis, the anastomotic portion comprising a first end and a second end and a surface therebetween to contact one side of the tissue and to magnetically couple to a magnet on another side of the tissue, wherein the magnet and the surface of the anastomotic portion are positionable to compress the tissue therebetween with sufficient force to create an anastomosis through the tissue; andat least one flexible portion protruding from the first end of the anastomotic portion along the longitudinal axis, the at least one flexible portion comprising a first articulation node located between the first end of the anastomotic portion and the at least one flexible portion, wherein the at least one flexible portion is bendable at the articulation node from an extended state extending along the longitudinal axis to a collapsed state relative to the longitudinal axis;wherein the articulation node enables the at least one flexible portion to move relative to the anastomotic portion, and wherein when the at least one flexible portion is in the extended state the anastomosis is formed by compressing the tissue between the surface of the anastomotic portion and the magnet and when the at least one flexible portion is in the collapsed state the magnet, the anastomotic portion, and the at least one flexible portion have a configuration suitable for passing through the anastomosis formed in the tissue.
  • 2. The apparatus of claim 1, wherein the anastomotic portion is formed of any one of a ferrous, magnetic, and paramagnetic material.
  • 3. The apparatus of claim 2, wherein the anastomotic portion is formed of any one of quaternary Iron, Neodymium, Iron, Boron, and Samarium comprises.
  • 4. The apparatus of claim 2, wherein the anastomotic portion is formed of any one of quaternary Iron, Neodymium, Iron, Boron, and Samarium particles incorporated in a rubber or plastic material.
  • 5. The apparatus of claim 1, wherein the anastomotic portion comprises a lumen extending through a longitudinal portion thereof.
  • 6. The apparatus of claim 5, wherein the at least one flexible portion comprises a lumen extending through a longitudinal portion thereof, and wherein the anastomotic portion and the at least one flexible portion are in fluid communication by way of the lumen.
  • 7. The apparatus of claim 1, wherein the anastomotic portion and the at least one flexible portion comprise a longitudinal tubular structure suitable for positioning within a hollow viscus and draining fluid therefrom.
  • 8. The apparatus of claim 1, wherein the anastomotic portion and the at least one flexible portion are formed of solid materials.
  • 9. The apparatus of claim 1, wherein the at least one flexible portion is formed of a polymeric material.
  • 10. The apparatus of claim 1, wherein the at least one flexible portion comprises a tapered portion.
  • 11. The apparatus of claim 1, comprising a second flexible portion protruding from the second end of the anastomotic portion along the longitudinal axis, the second flexible portion comprising a second articulation node located between the second end of anastomotic portion and the second flexible portion, wherein the second articulation node enables the second flexible portion to move relative to the anastomotic portion, and wherein when the second flexible portion is in the extended state the anastomosis is formed by compressing the tissue between the surface of the anastomotic portion and the magnet and when the second flexible portion is in the collapsed state the magnet, the anastomotic portion, and the at least one flexible portion and the second flexible portion have a configuration suitable for passing through the anastomosis formed in the tissue.
  • 12. The apparatus of claim 11, wherein the second articulation node comprises a circumferential groove.
  • 13. The apparatus of claim 1, wherein the first articulation node comprises a circumferential groove.
  • 14. A system for forming an anastomosis by compressing tissue between a magnet and a surface of an anastomotic portion of an anastomotic device wherein the anastomotic device is configurable between an extended state to form the anastomosis and a collapsed state to pass through the anastomosis, the system comprising: an anastomotic device comprising an anastomotic portion extending along a longitudinal axis, the anastomotic portion comprising a first end and a second end and a surface therebetween to contact one side of the tissue and to magnetically couple to a magnet on another side of the tissue; andat least one flexible portion protruding from the first end of the anastomotic portion along the longitudinal axis, the at least one flexible portion comprising an articulation node located between the first end of the anastomotic portion and the at least one flexible portion, wherein the at least one flexible portion is bendable at the articulation node from an extended state extending along the longitudinal axis to a collapsed state relative to the longitudinal axis, wherein the articulation node enables the at least one flexible portion to move relative to the anastomotic portion; anda magnet having a first end and a second end, wherein the magnet and the surface of the anastomotic portion are positionable to compress the tissue therebetween with sufficient force to create an anastomosis through the tissue; andwherein when the at least one flexible portion is in the extended state the anastomosis is formed by compressing the tissue between the surface of the anastomotic portion and the magnet and when the at least one flexible portion is in the collapsed state the magnet, the anastomotic portion, and the at least one flexible portion have a configuration suitable for passing through the anastomosis formed in the tissue.
  • 15. The system of claim 14, wherein the at least one flexible portion is adapted to move relative to the anastomotic portion when the magnet magnetically couples the anastomotic portion and the anastomosis is formed.
  • 16. The system of claim 14, wherein the magnet comprises a central lumen configured to slideably receive a pusher.
  • 17. The system of claim 14, wherein the magnet comprises radii formed at the first and second ends.
  • 18. The system of claim 14, wherein the magnet comprises a coating.
  • 19. The system of claim 18, wherein the coating comprises Chromium.
  • 20. The system of claim 14, comprising: a second flexible portion protruding from the second end of the anastomotic portion along the longitudinal axis, the second flexible portion comprising a second articulation node located between the second end of anastomotic portion and the second flexible portion, wherein the second articulation node enables the second flexible portion to move relative to the anastomotic portion, and wherein in the extended state the anastomosis is formed by compressing the tissue between the surface of the anastomotic portion and the magnet and in the collapsed state the magnet, the anastomotic portion, and the at least one flexible portion and the second flexible portion have a configuration suitable for passing through the anastomosis formed in the tissue.
  • 21. The system of claim 20, wherein the second articulation node comprises a circumferential groove.
  • 22. The system of claim 14, wherein the first articulation node comprises a circumferential groove.
  • 23. The system of claim 14, wherein the anastomotic portion is formed of a ferrous, magnetic, or paramagnetic material.
US Referenced Citations (1214)
Number Name Date Kind
645576 Telsa Mar 1900 A
649621 Tesla May 1900 A
787412 Tesla Apr 1905 A
1127948 Wappler Feb 1915 A
1482653 Lilly Feb 1924 A
1625602 Gould et al. Apr 1927 A
2028635 Wappler Jan 1936 A
2031682 Wappler et al. Feb 1936 A
2113246 Wappler Apr 1938 A
2155365 Rankin Apr 1939 A
2191858 Moore Feb 1940 A
2196620 Attarian Apr 1940 A
2388137 Graumlich Oct 1945 A
2493108 Casey, Jr. Jan 1950 A
2504152 Riker et al. Apr 1950 A
2938382 De Graaf May 1960 A
2952206 Becksted Sep 1960 A
3069195 Buck Dec 1962 A
3170471 Schnitzer Feb 1965 A
3435824 Gamponia Apr 1969 A
3470876 Barchilon Oct 1969 A
3595239 Petersen Jul 1971 A
3669487 Roberts et al. Jun 1972 A
3746881 Fitch et al. Jul 1973 A
3799672 Vurek Mar 1974 A
3854473 Matsuo Dec 1974 A
3946740 Bassett Mar 1976 A
3948251 Hosono Apr 1976 A
3994301 Agris Nov 1976 A
4011872 Komiya Mar 1977 A
4012812 Black Mar 1977 A
4085743 Yoon Apr 1978 A
4164225 Johnson et al. Aug 1979 A
4178920 Cawood, Jr. et al. Dec 1979 A
4207873 Kruy Jun 1980 A
4235238 Ogiu et al. Nov 1980 A
4258716 Sutherland Mar 1981 A
4269174 Adair May 1981 A
4278077 Mizumoto Jul 1981 A
4285344 Marshall Aug 1981 A
4311143 Komiya Jan 1982 A
4329980 Terada May 1982 A
4396021 Baumgartner Aug 1983 A
4406656 Hattler et al. Sep 1983 A
4452246 Bader et al. Jun 1984 A
4461281 Carson Jul 1984 A
4491132 Aikins Jan 1985 A
4527331 Lasner et al. Jul 1985 A
4527564 Eguchi et al. Jul 1985 A
4538594 Boebel et al. Sep 1985 A
D281104 Davison Oct 1985 S
4569347 Frisbie Feb 1986 A
4580551 Siegmund et al. Apr 1986 A
4646722 Silverstein et al. Mar 1987 A
4653476 Bonnet Mar 1987 A
4655219 Petruzzi Apr 1987 A
4669470 Brandfield Jun 1987 A
4671477 Cullen Jun 1987 A
4685447 Iversen et al. Aug 1987 A
4711240 Goldwasser et al. Dec 1987 A
4712545 Honkanen Dec 1987 A
4721116 Schintgen et al. Jan 1988 A
4733662 DeSatnick et al. Mar 1988 A
D295894 Sharkany et al. May 1988 S
4763669 Jaeger Aug 1988 A
4770188 Chikama Sep 1988 A
4815450 Patel Mar 1989 A
4823794 Pierce Apr 1989 A
4829999 Auth May 1989 A
4867140 Hovis et al. Sep 1989 A
4873979 Hanna Oct 1989 A
4880015 Nierman Nov 1989 A
4911148 Sosnowski et al. Mar 1990 A
4926860 Stice et al. May 1990 A
4938214 Specht et al. Jul 1990 A
4950273 Briggs Aug 1990 A
4950285 Wilk Aug 1990 A
4960133 Hewson Oct 1990 A
4977887 Gouda Dec 1990 A
4979950 Transue et al. Dec 1990 A
4984581 Stice Jan 1991 A
5007917 Evans Apr 1991 A
5010876 Henley et al. Apr 1991 A
5020514 Heckele Jun 1991 A
5020535 Parker et al. Jun 1991 A
5025778 Silverstein et al. Jun 1991 A
5033169 Bindon Jul 1991 A
5037433 Wilk et al. Aug 1991 A
5041129 Hayhurst et al. Aug 1991 A
5046513 Gatturna et al. Sep 1991 A
5050585 Takahashi Sep 1991 A
5052372 Shapiro Oct 1991 A
5065516 Dulebohn Nov 1991 A
5066295 Kozak et al. Nov 1991 A
5123913 Wilk et al. Jun 1992 A
5123914 Cope Jun 1992 A
5133727 Bales et al. Jul 1992 A
5147374 Fernandez Sep 1992 A
5174300 Bales et al. Dec 1992 A
5176126 Chikama Jan 1993 A
5190050 Nitzsche Mar 1993 A
5190555 Wetter et al. Mar 1993 A
5192284 Pleatman Mar 1993 A
5201752 Brown et al. Apr 1993 A
5201908 Jones Apr 1993 A
5203785 Slater Apr 1993 A
5203787 Noblitt et al. Apr 1993 A
5209747 Knoepfler May 1993 A
5217003 Wilk Jun 1993 A
5217453 Wilk Jun 1993 A
5219357 Honkanen et al. Jun 1993 A
5219358 Bendel et al. Jun 1993 A
5222362 Maus et al. Jun 1993 A
5222965 Haughton Jun 1993 A
5234437 Sepetka Aug 1993 A
5234453 Smith et al. Aug 1993 A
5235964 Abenaim Aug 1993 A
5242456 Nash et al. Sep 1993 A
5246424 Wilk Sep 1993 A
5259366 Reydel et al. Nov 1993 A
5263958 deGuillebon et al. Nov 1993 A
5273524 Fox et al. Dec 1993 A
5275607 Lo et al. Jan 1994 A
5284128 Hart Feb 1994 A
5284162 Wilk Feb 1994 A
5287845 Faul et al. Feb 1994 A
5290299 Fain et al. Mar 1994 A
5290302 Pericic Mar 1994 A
5295977 Cohen et al. Mar 1994 A
5297536 Wilk Mar 1994 A
5301061 Nakada et al. Apr 1994 A
5312333 Churinetz et al. May 1994 A
5312351 Gerrone May 1994 A
5312416 Spaeth et al. May 1994 A
5312423 Rosenbluth et al. May 1994 A
5318589 Lichtman Jun 1994 A
5320636 Slater Jun 1994 A
5325845 Adair Jul 1994 A
5330471 Eggers Jul 1994 A
5330486 Wilk Jul 1994 A
5330488 Goldrath Jul 1994 A
5330496 Alferness Jul 1994 A
5330502 Hassler et al. Jul 1994 A
5331971 Bales et al. Jul 1994 A
5334198 Hart et al. Aug 1994 A
5344428 Griffiths Sep 1994 A
5350391 Iacovelli Sep 1994 A
5352184 Goldberg et al. Oct 1994 A
5352222 Rydell Oct 1994 A
5354302 Ko Oct 1994 A
5354311 Kambin et al. Oct 1994 A
5356408 Rydell Oct 1994 A
5364408 Gordon Nov 1994 A
5364410 Failla et al. Nov 1994 A
5366466 Christian et al. Nov 1994 A
5366467 Lynch et al. Nov 1994 A
5368605 Miller, Jr. Nov 1994 A
5370647 Graber et al. Dec 1994 A
5370679 Atlee, III Dec 1994 A
5374273 Nakao et al. Dec 1994 A
5374275 Bradley et al. Dec 1994 A
5374277 Hassler Dec 1994 A
5377695 An Haack Jan 1995 A
5383877 Clarke Jan 1995 A
5383888 Zvenyatsky et al. Jan 1995 A
5386817 Jones Feb 1995 A
5391174 Weston Feb 1995 A
5392789 Slater et al. Feb 1995 A
5395386 Slater Mar 1995 A
5401248 Bencini Mar 1995 A
5403328 Shallman Apr 1995 A
5403342 Tovey et al. Apr 1995 A
5403348 Bonutti Apr 1995 A
5405073 Porter Apr 1995 A
5405359 Pierce Apr 1995 A
5409478 Gerry et al. Apr 1995 A
5417699 Klein et al. May 1995 A
5423821 Pasque Jun 1995 A
5433721 Hooven et al. Jul 1995 A
5439471 Kerr Aug 1995 A
5439478 Palmer Aug 1995 A
5441059 Dannan Aug 1995 A
5441499 Fritzsch Aug 1995 A
5443463 Stern et al. Aug 1995 A
5445638 Rydell et al. Aug 1995 A
5449021 Chikama Sep 1995 A
5456667 Ham et al. Oct 1995 A
5456684 Schmidt et al. Oct 1995 A
5458131 Wilk Oct 1995 A
5458583 McNeely et al. Oct 1995 A
5460168 Masubuchi et al. Oct 1995 A
5460629 Shlain et al. Oct 1995 A
5462561 Voda Oct 1995 A
5465731 Bell et al. Nov 1995 A
5467763 McMahon et al. Nov 1995 A
5468250 Paraschac et al. Nov 1995 A
5470308 Edwards et al. Nov 1995 A
5470320 Tiefenbrun et al. Nov 1995 A
5478347 Aranyi Dec 1995 A
5480404 Kammerer et al. Jan 1996 A
5482054 Slater et al. Jan 1996 A
5484451 Akopov et al. Jan 1996 A
5489256 Adair Feb 1996 A
5496347 Hashiguchi et al. Mar 1996 A
5499990 Schulken et al. Mar 1996 A
5499992 Meade et al. Mar 1996 A
5501692 Riza Mar 1996 A
5503616 Jones Apr 1996 A
5505686 Willis et al. Apr 1996 A
5507755 Gresl et al. Apr 1996 A
5511564 Wilk Apr 1996 A
5514157 Nicholas et al. May 1996 A
5522829 Michalos Jun 1996 A
5522830 Aranyi Jun 1996 A
5527321 Hinchliffe Jun 1996 A
5536248 Weaver et al. Jul 1996 A
5540648 Yoon Jul 1996 A
5554151 Hinchliffe Sep 1996 A
5555883 Avitall Sep 1996 A
5558133 Bortoli et al. Sep 1996 A
5562693 Devlin et al. Oct 1996 A
5569243 Kortenbach et al. Oct 1996 A
5569298 Schnell Oct 1996 A
5573540 Yoon Nov 1996 A
5578030 Levin Nov 1996 A
5582611 Tsuruta et al. Dec 1996 A
5582617 Klieman et al. Dec 1996 A
5584845 Hart Dec 1996 A
5591179 Edelstein Jan 1997 A
5593420 Eubanks, Jr. et al. Jan 1997 A
5595562 Grier Jan 1997 A
5597378 Jervis Jan 1997 A
5601573 Fogelberg et al. Feb 1997 A
5601588 Tonomura et al. Feb 1997 A
5604531 Iddan et al. Feb 1997 A
5607389 Edwards et al. Mar 1997 A
5607450 Zvenyatsky et al. Mar 1997 A
5613975 Christy Mar 1997 A
5618303 Marlow et al. Apr 1997 A
5620415 Lucey et al. Apr 1997 A
5624399 Ackerman Apr 1997 A
5624431 Gerry et al. Apr 1997 A
5626578 Tihon May 1997 A
5628732 Antoon, Jr. et al. May 1997 A
5630782 Adair May 1997 A
5643283 Younker Jul 1997 A
5643292 Hart Jul 1997 A
5643294 Tovey et al. Jul 1997 A
5644798 Shah Jul 1997 A
5645083 Essig et al. Jul 1997 A
5645565 Rudd et al. Jul 1997 A
5649372 Souza Jul 1997 A
5653677 Okada et al. Aug 1997 A
5653690 Booth et al. Aug 1997 A
5653722 Kieturakis Aug 1997 A
5662663 Shallman Sep 1997 A
5669875 van Eerdenburg Sep 1997 A
5681324 Kammerer et al. Oct 1997 A
5681330 Hughett et al. Oct 1997 A
5685820 Riek et al. Nov 1997 A
5690656 Cope et al. Nov 1997 A
5690660 Kauker et al. Nov 1997 A
5695448 Kimura et al. Dec 1997 A
5695505 Yoon Dec 1997 A
5695511 Cano et al. Dec 1997 A
5700275 Bell et al. Dec 1997 A
5702438 Avitall Dec 1997 A
5704892 Adair Jan 1998 A
5709708 Thal Jan 1998 A
5716326 Dannan Feb 1998 A
5730740 Wales et al. Mar 1998 A
5735849 Baden et al. Apr 1998 A
5741234 Aboul-Hosn Apr 1998 A
5741278 Stevens Apr 1998 A
5741285 McBrayer et al. Apr 1998 A
5746759 Meade et al. May 1998 A
5749881 Sackier et al. May 1998 A
5749889 Bacich et al. May 1998 A
5752951 Yanik May 1998 A
5755731 Grinberg May 1998 A
5766167 Eggers et al. Jun 1998 A
5766170 Eggers Jun 1998 A
5766205 Zvenyatsky et al. Jun 1998 A
5769849 Eggers Jun 1998 A
5779701 McBrayer et al. Jul 1998 A
5779716 Cano et al. Jul 1998 A
5779727 Orejola Jul 1998 A
5782859 Nicholas et al. Jul 1998 A
5782866 Wenstrom, Jr. Jul 1998 A
5791022 Bohman Aug 1998 A
5792113 Kramer et al. Aug 1998 A
5792153 Swain et al. Aug 1998 A
5792165 Klieman et al. Aug 1998 A
5797835 Green Aug 1998 A
5797928 Kogasaka Aug 1998 A
5797939 Yoon Aug 1998 A
5797941 Schulze et al. Aug 1998 A
5803903 Athas et al. Sep 1998 A
5808665 Green Sep 1998 A
5810806 Ritchart et al. Sep 1998 A
5810849 Kontos Sep 1998 A
5810865 Koscher et al. Sep 1998 A
5810876 Kelleher Sep 1998 A
5810877 Roth et al. Sep 1998 A
5813976 Filipi et al. Sep 1998 A
5814058 Carlson et al. Sep 1998 A
5817061 Goodwin et al. Oct 1998 A
5817107 Schaller Oct 1998 A
5817119 Klieman et al. Oct 1998 A
5819736 Avny et al. Oct 1998 A
5824071 Nelson et al. Oct 1998 A
5827281 Levin Oct 1998 A
5827299 Thomason et al. Oct 1998 A
5830231 Geiges, Jr. Nov 1998 A
5833700 Fogelberg et al. Nov 1998 A
5833703 Manushakian Nov 1998 A
5843017 Yoon Dec 1998 A
5843121 Yoon Dec 1998 A
5849022 Sakashita et al. Dec 1998 A
5853374 Hart et al. Dec 1998 A
5855585 Kontos Jan 1999 A
5860913 Yamaya et al. Jan 1999 A
5860995 Berkelaar Jan 1999 A
5868762 Cragg et al. Feb 1999 A
5876411 Kontos Mar 1999 A
5882331 Sasaki Mar 1999 A
5882344 Stouder, Jr. Mar 1999 A
5893846 Bales et al. Apr 1999 A
5893874 Bourque et al. Apr 1999 A
5893875 O'Connor et al. Apr 1999 A
5899919 Eubanks, Jr. et al. May 1999 A
5902254 Magram May 1999 A
5904702 Ek et al. May 1999 A
5908420 Parins et al. Jun 1999 A
5911737 Lee et al. Jun 1999 A
5916147 Boury Jun 1999 A
5921993 Yoon Jul 1999 A
5921997 Fogelberg et al. Jul 1999 A
5922008 Gimpelson Jul 1999 A
5925052 Simmons Jul 1999 A
5928255 Meade et al. Jul 1999 A
5928266 Kontos Jul 1999 A
5936536 Morris Aug 1999 A
5944718 Austin et al. Aug 1999 A
5951549 Richardson et al. Sep 1999 A
5954720 Wilson et al. Sep 1999 A
5954731 Yoon Sep 1999 A
5957943 Vaitekunas Sep 1999 A
5957953 DiPoto et al. Sep 1999 A
5971995 Rousseau Oct 1999 A
5976074 Moriyama Nov 1999 A
5976075 Beane et al. Nov 1999 A
5976130 McBrayer et al. Nov 1999 A
5976131 Guglielmi et al. Nov 1999 A
5980539 Kontos Nov 1999 A
5980556 Giordano et al. Nov 1999 A
5984938 Yoon Nov 1999 A
5984939 Yoon Nov 1999 A
5989182 Hori et al. Nov 1999 A
5993447 Blewett et al. Nov 1999 A
5997555 Kontos Dec 1999 A
6001120 Levin Dec 1999 A
6004269 Crowley et al. Dec 1999 A
6004330 Middleman et al. Dec 1999 A
6007566 Wenstrom, Jr. Dec 1999 A
6010515 Swain et al. Jan 2000 A
6012494 Balazs Jan 2000 A
6017356 Frederick et al. Jan 2000 A
6019770 Christoudias Feb 2000 A
6024708 Bales et al. Feb 2000 A
6024747 Kontos Feb 2000 A
6027522 Palmer Feb 2000 A
6030365 Laufer Feb 2000 A
6030634 Wu et al. Feb 2000 A
6033399 Gines Mar 2000 A
6036685 Mueller Mar 2000 A
6053927 Hamas Apr 2000 A
6066160 Colvin et al. May 2000 A
6068603 Suzuki May 2000 A
6068629 Haissaguerre et al. May 2000 A
6071233 Ishikawa et al. Jun 2000 A
6074408 Freeman Jun 2000 A
6086530 Mack Jul 2000 A
6090108 McBrayer et al. Jul 2000 A
6096046 Weiss Aug 2000 A
6102926 Tartaglia et al. Aug 2000 A
6106473 Violante et al. Aug 2000 A
6109852 Shahinpoor et al. Aug 2000 A
6110154 Shimomura et al. Aug 2000 A
6110183 Cope Aug 2000 A
6113593 Tu et al. Sep 2000 A
6117144 Nobles et al. Sep 2000 A
6117158 Measamer et al. Sep 2000 A
6139555 Hart et al. Oct 2000 A
6146391 Cigaina Nov 2000 A
6148222 Ramsey, III Nov 2000 A
6149653 Deslauriers Nov 2000 A
6149662 Pugliesi et al. Nov 2000 A
6159200 Verdura et al. Dec 2000 A
6165184 Verdura et al. Dec 2000 A
6168570 Ferrera Jan 2001 B1
6168605 Measamer et al. Jan 2001 B1
6170130 Hamilton et al. Jan 2001 B1
6179776 Adams et al. Jan 2001 B1
6179837 Hooven Jan 2001 B1
6183420 Douk et al. Feb 2001 B1
6190353 Makower et al. Feb 2001 B1
6190384 Ouchi Feb 2001 B1
6190399 Palmer et al. Feb 2001 B1
6203533 Ouchi Mar 2001 B1
6206872 Lafond et al. Mar 2001 B1
6206877 Kese et al. Mar 2001 B1
6214007 Anderson Apr 2001 B1
6228096 Marchand May 2001 B1
6234958 Snoke et al. May 2001 B1
6245079 Nobles et al. Jun 2001 B1
6246914 de la Rama et al. Jun 2001 B1
6258064 Smith et al. Jul 2001 B1
6261242 Roberts et al. Jul 2001 B1
6264664 Avellanet Jul 2001 B1
6270497 Sekino et al. Aug 2001 B1
6270505 Yoshida et al. Aug 2001 B1
6277136 Bonutti Aug 2001 B1
6283963 Regula Sep 2001 B1
6293909 Chu et al. Sep 2001 B1
6293952 Brosens et al. Sep 2001 B1
6296630 Altman et al. Oct 2001 B1
6322578 Houle et al. Nov 2001 B1
6326177 Schoenbach et al. Dec 2001 B1
6328730 Harkrider, Jr. Dec 2001 B1
6350267 Stefanchik Feb 2002 B1
6350278 Lenker et al. Feb 2002 B1
6352503 Matsui et al. Mar 2002 B1
6352543 Cole Mar 2002 B1
6355035 Manushakian Mar 2002 B1
6361534 Chen et al. Mar 2002 B1
6371956 Wilson et al. Apr 2002 B1
6379366 Fleischman et al. Apr 2002 B1
6383195 Richard May 2002 B1
6383197 Conlon et al. May 2002 B1
6391029 Hooven et al. May 2002 B1
6402735 Langevin Jun 2002 B1
6406440 Stefanchik Jun 2002 B1
6409727 Bales et al. Jun 2002 B1
6409733 Conlon et al. Jun 2002 B1
6427089 Knowlton Jul 2002 B1
6431500 Jacobs et al. Aug 2002 B1
6443970 Schulze et al. Sep 2002 B1
6443988 Felt et al. Sep 2002 B2
6447511 Slater Sep 2002 B1
6447523 Middleman et al. Sep 2002 B1
6454783 Piskun Sep 2002 B1
6454785 De Hoyos Garza Sep 2002 B2
6458076 Pruitt Oct 2002 B1
6464701 Hooven et al. Oct 2002 B1
6464702 Schulze et al. Oct 2002 B2
6475104 Lutz et al. Nov 2002 B1
6485411 Konstorum et al. Nov 2002 B1
6489745 Koreis Dec 2002 B1
6491626 Stone et al. Dec 2002 B1
6491627 Komi Dec 2002 B1
6491691 Morley et al. Dec 2002 B1
6493590 Wessman et al. Dec 2002 B1
6494893 Dubrul et al. Dec 2002 B2
6500176 Truckai et al. Dec 2002 B1
6503192 Ouchi Jan 2003 B1
6506190 Walshe Jan 2003 B1
6508827 Manhes Jan 2003 B1
6514239 Shimmura et al. Feb 2003 B2
6520954 Ouchi Feb 2003 B2
6543456 Freeman Apr 2003 B1
6551270 Bimbo et al. Apr 2003 B1
6554829 Schulze et al. Apr 2003 B2
6558384 Mayenberger May 2003 B2
6562035 Levin May 2003 B1
6562052 Nobles et al. May 2003 B2
6569159 Edwards et al. May 2003 B1
6572629 Kalloo et al. Jun 2003 B2
6572635 Bonutti Jun 2003 B1
6575988 Rousseau Jun 2003 B2
6579311 Makower Jun 2003 B1
6585642 Christopher Jul 2003 B2
6585717 Wittenberger et al. Jul 2003 B1
6587750 Gerbi et al. Jul 2003 B2
6592559 Pakter et al. Jul 2003 B1
6592603 Lasner Jul 2003 B2
6602262 Griego et al. Aug 2003 B2
6605105 Cuschieri et al. Aug 2003 B1
6610072 Christy et al. Aug 2003 B1
6610074 Santilli Aug 2003 B2
6620193 Lau et al. Sep 2003 B1
6623448 Slater Sep 2003 B2
6626919 Swanstrom Sep 2003 B1
6632229 Yamanouchi Oct 2003 B1
6638286 Burbank et al. Oct 2003 B1
6652521 Schulze Nov 2003 B2
6652551 Heiss Nov 2003 B1
6656194 Gannoe et al. Dec 2003 B1
6663641 Kovac et al. Dec 2003 B1
6666854 Lange Dec 2003 B1
6672338 Esashi et al. Jan 2004 B1
6673058 Snow Jan 2004 B2
6673087 Chang et al. Jan 2004 B1
6679882 Kornerup Jan 2004 B1
6685628 Vu Feb 2004 B2
6685724 Haluck Feb 2004 B1
6692445 Roberts et al. Feb 2004 B2
6692462 Mackenzie et al. Feb 2004 B2
6699180 Kobayashi Mar 2004 B2
6699256 Logan et al. Mar 2004 B1
6699263 Cope Mar 2004 B2
6706018 Westlund et al. Mar 2004 B2
6708066 Herbst et al. Mar 2004 B2
6709445 Boebel et al. Mar 2004 B2
6716226 Sixto, Jr. et al. Apr 2004 B2
6736822 McClellan et al. May 2004 B2
6740030 Martone et al. May 2004 B2
6743240 Smith et al. Jun 2004 B2
6749560 Konstorum et al. Jun 2004 B1
6749609 Lunsford et al. Jun 2004 B1
6752768 Burdorff et al. Jun 2004 B2
6752811 Chu et al. Jun 2004 B2
6752822 Jespersen Jun 2004 B2
6761685 Adams et al. Jul 2004 B2
6761718 Madsen Jul 2004 B2
6773434 Ciarrocca Aug 2004 B2
6780151 Grabover et al. Aug 2004 B2
6780352 Jacobson Aug 2004 B2
6783491 Saadat et al. Aug 2004 B2
6786864 Matsuura et al. Sep 2004 B2
6790173 Saadat et al. Sep 2004 B2
6795728 Chornenky et al. Sep 2004 B2
6800056 Tartaglia et al. Oct 2004 B2
6808491 Kortenbach et al. Oct 2004 B2
6824548 Smith et al. Nov 2004 B2
6836688 Ingle et al. Dec 2004 B2
6837847 Ewers et al. Jan 2005 B2
6843794 Sixto, Jr. et al. Jan 2005 B2
6861250 Cole et al. Mar 2005 B1
6866627 Nozue Mar 2005 B2
6878106 Herrmann Apr 2005 B1
6878110 Yang et al. Apr 2005 B2
6881216 Di Caprio et al. Apr 2005 B2
6884213 Raz et al. Apr 2005 B2
6887255 Shimm May 2005 B2
6889089 Behl et al. May 2005 B2
6896683 Gadberry et al. May 2005 B1
6896692 Ginn et al. May 2005 B2
6908427 Fleener et al. Jun 2005 B2
6908476 Jud et al. Jun 2005 B2
6916284 Moriyama Jul 2005 B2
6918871 Schulze Jul 2005 B2
6926725 Cooke et al. Aug 2005 B2
6932810 Ryan Aug 2005 B2
6932824 Roop et al. Aug 2005 B1
6932827 Cole Aug 2005 B2
6939327 Hall et al. Sep 2005 B2
6942613 Ewers et al. Sep 2005 B2
6945472 Wuttke et al. Sep 2005 B2
6945979 Kortenbach et al. Sep 2005 B2
6958035 Friedman et al. Oct 2005 B2
6960162 Saadat et al. Nov 2005 B2
6960163 Ewers et al. Nov 2005 B2
6962587 Johnson et al. Nov 2005 B2
6964662 Kidooka Nov 2005 B2
6966909 Marshall et al. Nov 2005 B2
6966919 Sixto, Jr. et al. Nov 2005 B2
6967462 Landis Nov 2005 B1
6971988 Orban, III Dec 2005 B2
6972017 Smith et al. Dec 2005 B2
6974411 Belson Dec 2005 B2
6976992 Sachatello et al. Dec 2005 B2
6984203 Tartaglia et al. Jan 2006 B2
6984205 Gazdzinski Jan 2006 B2
6986774 Middleman et al. Jan 2006 B2
6988987 Ishikawa et al. Jan 2006 B2
6989028 Lashinski et al. Jan 2006 B2
6991627 Madhani et al. Jan 2006 B2
6991631 Woloszko et al. Jan 2006 B2
6994708 Manzo Feb 2006 B2
6997931 Sauer et al. Feb 2006 B2
7000818 Shelton, IV et al. Feb 2006 B2
7001341 Gellman et al. Feb 2006 B2
7008375 Weisel Mar 2006 B2
7009634 Iddan et al. Mar 2006 B2
7010340 Scarantino et al. Mar 2006 B2
7020531 Colliou et al. Mar 2006 B1
7025580 Heagy et al. Apr 2006 B2
7029435 Nakao Apr 2006 B2
7029438 Morin et al. Apr 2006 B2
7029450 Gellman Apr 2006 B2
7035680 Partridge et al. Apr 2006 B2
7037290 Gardeski et al. May 2006 B2
7041052 Saadat et al. May 2006 B2
7052489 Griego et al. May 2006 B2
7060024 Long et al. Jun 2006 B2
7060025 Long et al. Jun 2006 B2
7063697 Slater Jun 2006 B2
7063715 Onuki et al. Jun 2006 B2
7066879 Fowler et al. Jun 2006 B2
7066936 Ryan Jun 2006 B2
7070602 Smith et al. Jul 2006 B2
7076305 Imran et al. Jul 2006 B2
7083618 Couture et al. Aug 2006 B2
7083620 Jahns et al. Aug 2006 B2
7083629 Weller et al. Aug 2006 B2
7083635 Ginn Aug 2006 B2
7087071 Nicholas et al. Aug 2006 B2
7090673 Dycus et al. Aug 2006 B2
7090685 Kortenbach et al. Aug 2006 B2
7093518 Gmeilbauer Aug 2006 B2
7101371 Dycus et al. Sep 2006 B2
7101372 Dycus et al. Sep 2006 B2
7101373 Dycus et al. Sep 2006 B2
7105000 McBrayer Sep 2006 B2
7105005 Blake Sep 2006 B2
7108703 Danitz et al. Sep 2006 B2
7112208 Morris et al. Sep 2006 B2
7115092 Park et al. Oct 2006 B2
7117703 Kato et al. Oct 2006 B2
7118531 Krill Oct 2006 B2
7118578 West, Jr. et al. Oct 2006 B2
7118587 Dycus et al. Oct 2006 B2
7128708 Saadat et al. Oct 2006 B2
RE39415 Bales et al. Nov 2006 E
7131978 Sancoff et al. Nov 2006 B2
7131979 DiCarlo et al. Nov 2006 B2
7131980 Field et al. Nov 2006 B1
7137980 Buysse et al. Nov 2006 B2
7137981 Long Nov 2006 B2
7146984 Stack et al. Dec 2006 B2
7147650 Lee Dec 2006 B2
7150097 Sremcich et al. Dec 2006 B2
7150655 Mastrototaro et al. Dec 2006 B2
7152488 Hedrich et al. Dec 2006 B2
7153321 Andrews Dec 2006 B2
7163525 Franer Jan 2007 B2
7172714 Jacobson Feb 2007 B2
7179254 Pendekanti et al. Feb 2007 B2
7188627 Nelson et al. Mar 2007 B2
7195612 Van Sloten et al. Mar 2007 B2
7195631 Dumbauld Mar 2007 B2
7204820 Akahoshi Apr 2007 B2
7208005 Frecker et al. Apr 2007 B2
7211092 Hughett May 2007 B2
7220227 Sasaki et al. May 2007 B2
7223272 Francese et al. May 2007 B2
7232414 Gonzalez Jun 2007 B2
7232445 Kortenbach et al. Jun 2007 B2
7241290 Doyle et al. Jul 2007 B2
7244228 Lubowski Jul 2007 B2
7250027 Barry Jul 2007 B2
7252660 Kunz Aug 2007 B2
7255675 Gertner et al. Aug 2007 B2
7270663 Nakao Sep 2007 B2
7294139 Gengler Nov 2007 B1
7301250 Cassel Nov 2007 B2
7306597 Manzo Dec 2007 B2
7308828 Hashimoto Dec 2007 B2
7318802 Suzuki et al. Jan 2008 B2
7320695 Carroll Jan 2008 B2
7322934 Miyake et al. Jan 2008 B2
7323006 Andreas et al. Jan 2008 B2
7329256 Johnson et al. Feb 2008 B2
7329257 Kanehira et al. Feb 2008 B2
7329383 Stinson Feb 2008 B2
7344536 Lunsford et al. Mar 2008 B1
7352387 Yamamoto Apr 2008 B2
7364582 Lee Apr 2008 B2
7371215 Colliou et al. May 2008 B2
7381216 Buzzard et al. Jun 2008 B2
7393322 Wenchell Jul 2008 B2
7402162 Ouchi Jul 2008 B2
7404791 Linares et al. Jul 2008 B2
7413563 Corcoran et al. Aug 2008 B2
7416554 Lam et al. Aug 2008 B2
7422590 Kupferschmid et al. Sep 2008 B2
7435257 Lashinski et al. Oct 2008 B2
7452327 Durgin et al. Nov 2008 B2
7455208 Wales et al. Nov 2008 B2
7468066 Vargas et al. Dec 2008 B2
7488295 Burbank et al. Feb 2009 B2
7497867 Lasner et al. Mar 2009 B2
7507200 Okada Mar 2009 B2
7524281 Chu et al. Apr 2009 B2
7524302 Tower Apr 2009 B2
7534228 Williams May 2009 B2
7540872 Schechter et al. Jun 2009 B2
7544203 Chin et al. Jun 2009 B2
7548040 Lee et al. Jun 2009 B2
7549564 Boudreaux Jun 2009 B2
7553278 Kucklick Jun 2009 B2
7553298 Hunt et al. Jun 2009 B2
7559887 Dannan Jul 2009 B2
7559916 Smith et al. Jul 2009 B2
7560006 Rakos et al. Jul 2009 B2
7561916 Hunt et al. Jul 2009 B2
7566334 Christian et al. Jul 2009 B2
7575144 Ortiz et al. Aug 2009 B2
7575548 Takemoto et al. Aug 2009 B2
7579550 Dayton et al. Aug 2009 B2
7582096 Gellman et al. Sep 2009 B2
7588177 Racenet Sep 2009 B2
7588557 Nakao Sep 2009 B2
7618398 Holman et al. Nov 2009 B2
7632250 Smith et al. Dec 2009 B2
7635373 Ortiz Dec 2009 B2
7637903 Lentz et al. Dec 2009 B2
7651483 Byrum et al. Jan 2010 B2
7651509 Bojarski et al. Jan 2010 B2
7654431 Hueil et al. Feb 2010 B2
7655004 Long Feb 2010 B2
7662089 Okada et al. Feb 2010 B2
7666180 Holsten et al. Feb 2010 B2
7674259 Shadduck Mar 2010 B2
7713189 Hanke May 2010 B2
7713270 Suzuki May 2010 B2
7736374 Vaughan et al. Jun 2010 B2
7744615 Couture Jun 2010 B2
7758577 Nobis et al. Jul 2010 B2
7762998 Birk et al. Jul 2010 B2
7771416 Spivey et al. Aug 2010 B2
7780683 Roue et al. Aug 2010 B2
7780691 Stefanchik Aug 2010 B2
7794409 Damarati Sep 2010 B2
7794475 Hess et al. Sep 2010 B2
7815662 Spivey et al. Oct 2010 B2
7828186 Wales Nov 2010 B2
7837615 Le et al. Nov 2010 B2
7846171 Kullas et al. Dec 2010 B2
7850660 Uth et al. Dec 2010 B2
7857183 Shelton, IV Dec 2010 B2
7862546 Conlon et al. Jan 2011 B2
7867216 Wahr et al. Jan 2011 B2
7892220 Faller et al. Feb 2011 B2
7896887 Rimbaugh et al. Mar 2011 B2
7909809 Scopton et al. Mar 2011 B2
7914513 Voorhees, Jr. Mar 2011 B2
7918869 Saadat et al. Apr 2011 B2
7931624 Smith et al. Apr 2011 B2
7945332 Schechter May 2011 B2
7947000 Vargas et al. May 2011 B2
7955298 Carroll et al. Jun 2011 B2
7963975 Criscuolo Jun 2011 B2
7988685 Ziaie et al. Aug 2011 B2
8075587 Ginn Dec 2011 B2
8118821 Mouw Feb 2012 B2
20010049497 Kalloo et al. Dec 2001 A1
20020022771 Diokno et al. Feb 2002 A1
20020022857 Goldsteen et al. Feb 2002 A1
20020023353 Ting-Kung Feb 2002 A1
20020029055 Bonutti Mar 2002 A1
20020042562 Meron et al. Apr 2002 A1
20020049439 Mulier et al. Apr 2002 A1
20020068945 Sixto, Jr. et al. Jun 2002 A1
20020078967 Sixto, Jr. et al. Jun 2002 A1
20020082516 Stefanchik Jun 2002 A1
20020091391 Cole et al. Jul 2002 A1
20020095164 Andreas et al. Jul 2002 A1
20020107530 Sauer et al. Aug 2002 A1
20020133115 Gordon et al. Sep 2002 A1
20020138086 Sixto, Jr. et al. Sep 2002 A1
20020147456 Diduch et al. Oct 2002 A1
20020183591 Matsuura et al. Dec 2002 A1
20030023255 Miles et al. Jan 2003 A1
20030036679 Kortenbach et al. Feb 2003 A1
20030069602 Jacobs et al. Apr 2003 A1
20030083681 Moutafis et al. May 2003 A1
20030114732 Webler et al. Jun 2003 A1
20030120257 Houston et al. Jun 2003 A1
20030124009 Ravi et al. Jul 2003 A1
20030130564 Martone et al. Jul 2003 A1
20030130656 Levin Jul 2003 A1
20030158521 Ameri Aug 2003 A1
20030167062 Gambale et al. Sep 2003 A1
20030171651 Page et al. Sep 2003 A1
20030176880 Long et al. Sep 2003 A1
20030191497 Cope Oct 2003 A1
20030195565 Bonutti Oct 2003 A1
20030216611 Vu Nov 2003 A1
20030216615 Ouchi Nov 2003 A1
20030220545 Ouchi Nov 2003 A1
20030225312 Suzuki et al. Dec 2003 A1
20030225332 Okada et al. Dec 2003 A1
20030229269 Humphrey Dec 2003 A1
20030229371 Whitworth Dec 2003 A1
20030236549 Bonadio et al. Dec 2003 A1
20040002683 Nicholson et al. Jan 2004 A1
20040002735 Lizardi et al. Jan 2004 A1
20040034369 Sauer et al. Feb 2004 A1
20040098007 Heiss May 2004 A1
20040101456 Kuroshima et al. May 2004 A1
20040116948 Sixto, Jr. et al. Jun 2004 A1
20040127940 Ginn et al. Jul 2004 A1
20040133077 Obenchain et al. Jul 2004 A1
20040133089 Kilcoyne et al. Jul 2004 A1
20040136779 Bhaskar Jul 2004 A1
20040138525 Saadat et al. Jul 2004 A1
20040138529 Wiltshire et al. Jul 2004 A1
20040138587 Lyons, IV Jul 2004 A1
20040161451 Pierce et al. Aug 2004 A1
20040186350 Brenneman et al. Sep 2004 A1
20040193009 Jaffe et al. Sep 2004 A1
20040193146 Lee et al. Sep 2004 A1
20040193186 Kortenbach et al. Sep 2004 A1
20040193188 Francese Sep 2004 A1
20040193189 Kortenbach et al. Sep 2004 A1
20040193200 Dworschak et al. Sep 2004 A1
20040199052 Banik et al. Oct 2004 A1
20040206859 Chong et al. Oct 2004 A1
20040210245 Erickson et al. Oct 2004 A1
20040215058 Zirps et al. Oct 2004 A1
20040225183 Michlitsch et al. Nov 2004 A1
20040225186 Horne, Jr. et al. Nov 2004 A1
20040230095 Stefanchik et al. Nov 2004 A1
20040230096 Stefanchik et al. Nov 2004 A1
20040230097 Stefanchik et al. Nov 2004 A1
20040230161 Zeiner Nov 2004 A1
20040249246 Campos Dec 2004 A1
20040249367 Saadat et al. Dec 2004 A1
20040249394 Morris et al. Dec 2004 A1
20040249443 Shanley et al. Dec 2004 A1
20050004515 Hart et al. Jan 2005 A1
20050033265 Engel et al. Feb 2005 A1
20050033277 Clague et al. Feb 2005 A1
20050033319 Gambale et al. Feb 2005 A1
20050033333 Smith et al. Feb 2005 A1
20050043690 Todd Feb 2005 A1
20050049616 Rivera et al. Mar 2005 A1
20050065397 Saadat et al. Mar 2005 A1
20050065517 Chin Mar 2005 A1
20050070754 Nobis et al. Mar 2005 A1
20050070763 Nobis et al. Mar 2005 A1
20050070764 Nobis et al. Mar 2005 A1
20050080413 Canady Apr 2005 A1
20050085693 Belson et al. Apr 2005 A1
20050085832 Sancoff et al. Apr 2005 A1
20050090837 Sixto, Jr. et al. Apr 2005 A1
20050090838 Sixto, Jr. et al. Apr 2005 A1
20050101837 Kalloo et al. May 2005 A1
20050101838 Camillocci et al. May 2005 A1
20050107663 Saadat et al. May 2005 A1
20050107664 Kalloo et al. May 2005 A1
20050110881 Glukhovsky et al. May 2005 A1
20050113847 Gadberry et al. May 2005 A1
20050119613 Moenning et al. Jun 2005 A1
20050124855 Jaffe et al. Jun 2005 A1
20050125010 Smith et al. Jun 2005 A1
20050131279 Boulais et al. Jun 2005 A1
20050131457 Douglas et al. Jun 2005 A1
20050137454 Saadat et al. Jun 2005 A1
20050143647 Minai et al. Jun 2005 A1
20050143690 High Jun 2005 A1
20050143774 Polo Jun 2005 A1
20050143803 Watson et al. Jun 2005 A1
20050149087 Ahlberg et al. Jul 2005 A1
20050149096 Hilal et al. Jul 2005 A1
20050159648 Freed Jul 2005 A1
20050165272 Okada et al. Jul 2005 A1
20050165378 Heinrich et al. Jul 2005 A1
20050165411 Orban, III Jul 2005 A1
20050165429 Douglas et al. Jul 2005 A1
20050182429 Yamanouchi Aug 2005 A1
20050192478 Williams et al. Sep 2005 A1
20050192598 Johnson et al. Sep 2005 A1
20050192602 Manzo Sep 2005 A1
20050192654 Chanduszko et al. Sep 2005 A1
20050209624 Vijay Sep 2005 A1
20050215858 Vail Sep 2005 A1
20050216050 Sepetka et al. Sep 2005 A1
20050228406 Bose Oct 2005 A1
20050234297 Devierre et al. Oct 2005 A1
20050250983 Tremaglio et al. Nov 2005 A1
20050250990 Le et al. Nov 2005 A1
20050250993 Jaeger Nov 2005 A1
20050251166 Vaughan et al. Nov 2005 A1
20050251176 Swanstrom et al. Nov 2005 A1
20050261674 Nobis et al. Nov 2005 A1
20050267492 Poncet et al. Dec 2005 A1
20050272975 McWeeney et al. Dec 2005 A1
20050272977 Saadat et al. Dec 2005 A1
20050273084 Hinman et al. Dec 2005 A1
20050277945 Saadat et al. Dec 2005 A1
20050277951 Smith et al. Dec 2005 A1
20050277952 Arp et al. Dec 2005 A1
20050277954 Smith et al. Dec 2005 A1
20050277955 Palmer et al. Dec 2005 A1
20050277956 Francese et al. Dec 2005 A1
20050277957 Kuhns et al. Dec 2005 A1
20050283118 Uth et al. Dec 2005 A1
20050283119 Uth et al. Dec 2005 A1
20050288555 Binmoeller Dec 2005 A1
20060004406 Wehrstein et al. Jan 2006 A1
20060004409 Nobis et al. Jan 2006 A1
20060004410 Nobis et al. Jan 2006 A1
20060015009 Jaffe et al. Jan 2006 A1
20060020167 Sitzmann Jan 2006 A1
20060020247 Kagan et al. Jan 2006 A1
20060025654 Suzuki et al. Feb 2006 A1
20060025781 Young et al. Feb 2006 A1
20060025812 Shelton, IV Feb 2006 A1
20060025819 Nobis et al. Feb 2006 A1
20060036267 Saadat et al. Feb 2006 A1
20060041188 Dirusso et al. Feb 2006 A1
20060058582 Maahs et al. Mar 2006 A1
20060058776 Bilsbury Mar 2006 A1
20060069396 Meade et al. Mar 2006 A1
20060069424 Acosta et al. Mar 2006 A1
20060069425 Hillis et al. Mar 2006 A1
20060074413 Behzadian Apr 2006 A1
20060079890 Guerra Apr 2006 A1
20060089528 Tartaglia et al. Apr 2006 A1
20060095031 Ormsby May 2006 A1
20060095060 Mayenberger et al. May 2006 A1
20060100687 Fahey et al. May 2006 A1
20060106423 Weisel et al. May 2006 A1
20060111209 Hinman et al. May 2006 A1
20060111210 Hinman May 2006 A1
20060111704 Brenneman et al. May 2006 A1
20060129166 Lavelle Jun 2006 A1
20060135962 Kick et al. Jun 2006 A1
20060135971 Swanstrom et al. Jun 2006 A1
20060135984 Kramer et al. Jun 2006 A1
20060142644 Mulac et al. Jun 2006 A1
20060142652 Keenan Jun 2006 A1
20060142790 Gertner Jun 2006 A1
20060142798 Holman et al. Jun 2006 A1
20060149131 Or Jul 2006 A1
20060149132 Iddan Jul 2006 A1
20060149135 Paz Jul 2006 A1
20060161190 Gadberry et al. Jul 2006 A1
20060167416 Mathis et al. Jul 2006 A1
20060167482 Swain et al. Jul 2006 A1
20060178560 Saadat et al. Aug 2006 A1
20060183975 Saadat et al. Aug 2006 A1
20060184161 Maahs et al. Aug 2006 A1
20060189844 Tien Aug 2006 A1
20060189845 Maahs et al. Aug 2006 A1
20060190027 Downey Aug 2006 A1
20060195084 Slater Aug 2006 A1
20060200005 Bjork et al. Sep 2006 A1
20060200169 Sniffin Sep 2006 A1
20060200170 Aranyi Sep 2006 A1
20060200199 Bonutti et al. Sep 2006 A1
20060217665 Prosek Sep 2006 A1
20060217697 Lau et al. Sep 2006 A1
20060217742 Messerly et al. Sep 2006 A1
20060217743 Messerly et al. Sep 2006 A1
20060229639 Whitfield Oct 2006 A1
20060229640 Whitfield Oct 2006 A1
20060237022 Chen et al. Oct 2006 A1
20060237023 Cox et al. Oct 2006 A1
20060241570 Wilk Oct 2006 A1
20060247576 Poncet Nov 2006 A1
20060247673 Voegele et al. Nov 2006 A1
20060253004 Frisch et al. Nov 2006 A1
20060253039 McKenna et al. Nov 2006 A1
20060258907 Stefanchik et al. Nov 2006 A1
20060258908 Stefanchik et al. Nov 2006 A1
20060258910 Stefanchik et al. Nov 2006 A1
20060258954 Timberlake et al. Nov 2006 A1
20060258955 Hoffman et al. Nov 2006 A1
20060259010 Stefanchik et al. Nov 2006 A1
20060264752 Rubinsky et al. Nov 2006 A1
20060264904 Kerby et al. Nov 2006 A1
20060264930 Nishimura Nov 2006 A1
20060270902 Igarashi et al. Nov 2006 A1
20060271102 Bosshard et al. Nov 2006 A1
20060276835 Uchida Dec 2006 A1
20060281970 Stokes et al. Dec 2006 A1
20060282106 Cole et al. Dec 2006 A1
20060285732 Horn et al. Dec 2006 A1
20060287644 Inganas et al. Dec 2006 A1
20060287666 Saadat et al. Dec 2006 A1
20060293626 Byrum et al. Dec 2006 A1
20070002135 Glukhovsky Jan 2007 A1
20070005019 Okishige Jan 2007 A1
20070010801 Chen et al. Jan 2007 A1
20070015965 Cox et al. Jan 2007 A1
20070016225 Nakao Jan 2007 A1
20070032700 Fowler et al. Feb 2007 A1
20070032701 Fowler et al. Feb 2007 A1
20070043261 Watanabe et al. Feb 2007 A1
20070043345 Davalos et al. Feb 2007 A1
20070049800 Boulais Mar 2007 A1
20070049902 Griffin et al. Mar 2007 A1
20070051375 Milliman Mar 2007 A1
20070060880 Gregorich et al. Mar 2007 A1
20070067017 Trapp Mar 2007 A1
20070073102 Matsuno et al. Mar 2007 A1
20070073269 Becker Mar 2007 A1
20070079924 Saadat et al. Apr 2007 A1
20070088370 Kahle et al. Apr 2007 A1
20070100375 Mikkaichi et al. May 2007 A1
20070100376 Mikkaichi et al. May 2007 A1
20070106118 Moriyama May 2007 A1
20070112251 Nakhuda May 2007 A1
20070112331 Weber et al. May 2007 A1
20070112342 Pearson et al. May 2007 A1
20070112383 Conlon et al. May 2007 A1
20070112384 Conlon et al. May 2007 A1
20070112385 Conlon May 2007 A1
20070112417 Shanley et al. May 2007 A1
20070112425 Schaller et al. May 2007 A1
20070118115 Artale et al. May 2007 A1
20070123840 Cox May 2007 A1
20070129605 Schaaf Jun 2007 A1
20070129719 Kendale et al. Jun 2007 A1
20070129760 Demarais et al. Jun 2007 A1
20070135709 Rioux et al. Jun 2007 A1
20070135803 Belson Jun 2007 A1
20070142706 Matsui et al. Jun 2007 A1
20070142780 Van Lue Jun 2007 A1
20070154460 Kraft et al. Jul 2007 A1
20070156028 Van Lue et al. Jul 2007 A1
20070156127 Rioux et al. Jul 2007 A1
20070161855 Mikkaichi et al. Jul 2007 A1
20070162101 Burgermeister et al. Jul 2007 A1
20070173691 Yokoi et al. Jul 2007 A1
20070173869 Gannoe et al. Jul 2007 A1
20070173870 Zacharias Jul 2007 A2
20070173872 Neuenfeldt Jul 2007 A1
20070179525 Frecker et al. Aug 2007 A1
20070179530 Tieu et al. Aug 2007 A1
20070197865 Miyake et al. Aug 2007 A1
20070198057 Gelbart et al. Aug 2007 A1
20070203487 Sugita Aug 2007 A1
20070208336 Kim et al. Sep 2007 A1
20070208364 Smith et al. Sep 2007 A1
20070213754 Mikkaichi et al. Sep 2007 A1
20070225554 Maseda et al. Sep 2007 A1
20070233040 Macnamara et al. Oct 2007 A1
20070244358 Lee Oct 2007 A1
20070250038 Boulais Oct 2007 A1
20070250057 Nobis et al. Oct 2007 A1
20070255096 Stefanchik et al. Nov 2007 A1
20070255100 Barlow et al. Nov 2007 A1
20070255273 Fernandez et al. Nov 2007 A1
20070255303 Bakos et al. Nov 2007 A1
20070255306 Conlon et al. Nov 2007 A1
20070260112 Rahmani Nov 2007 A1
20070260117 Zwolinski et al. Nov 2007 A1
20070260121 Bakos et al. Nov 2007 A1
20070260273 Cropper et al. Nov 2007 A1
20070270629 Charles Nov 2007 A1
20070270889 Conlon et al. Nov 2007 A1
20070270895 Nobis et al. Nov 2007 A1
20070270907 Stokes et al. Nov 2007 A1
20070282371 Lee et al. Dec 2007 A1
20070293727 Goldfarb et al. Dec 2007 A1
20070299387 Williams et al. Dec 2007 A1
20080004650 George Jan 2008 A1
20080015409 Barlow et al. Jan 2008 A1
20080015552 Doyle et al. Jan 2008 A1
20080021416 Arai et al. Jan 2008 A1
20080022927 Zhang et al. Jan 2008 A1
20080027387 Grabinsky Jan 2008 A1
20080033451 Rieber et al. Feb 2008 A1
20080051629 Sugiyama et al. Feb 2008 A1
20080051735 Measamer et al. Feb 2008 A1
20080058586 Karpiel Mar 2008 A1
20080065169 Colliou et al. Mar 2008 A1
20080071264 Azure Mar 2008 A1
20080086172 Martin et al. Apr 2008 A1
20080097159 Ishiguro Apr 2008 A1
20080097472 Agmon et al. Apr 2008 A1
20080097483 Ortiz et al. Apr 2008 A1
20080103527 Martin et al. May 2008 A1
20080114384 Chang et al. May 2008 A1
20080119870 Williams May 2008 A1
20080119891 Miles et al. May 2008 A1
20080125796 Graham May 2008 A1
20080132892 Lunsford et al. Jun 2008 A1
20080139882 Fujimori Jun 2008 A1
20080147113 Nobis et al. Jun 2008 A1
20080171907 Long et al. Jul 2008 A1
20080177135 Muyari et al. Jul 2008 A1
20080188868 Weitzner et al. Aug 2008 A1
20080200755 Bakos Aug 2008 A1
20080200762 Stokes et al. Aug 2008 A1
20080200911 Long Aug 2008 A1
20080200933 Bakos et al. Aug 2008 A1
20080200934 Fox Aug 2008 A1
20080208213 Benjamin et al. Aug 2008 A1
20080221587 Schwartz Sep 2008 A1
20080228213 Blakeney et al. Sep 2008 A1
20080230972 Ganley Sep 2008 A1
20080234696 Taylor et al. Sep 2008 A1
20080243106 Coe et al. Oct 2008 A1
20080243148 Mikkaichi et al. Oct 2008 A1
20080243176 Weitzner et al. Oct 2008 A1
20080249567 Kaplan Oct 2008 A1
20080262540 Bangera et al. Oct 2008 A1
20080269782 Stefanchik et al. Oct 2008 A1
20080269783 Griffith Oct 2008 A1
20080275474 Martin et al. Nov 2008 A1
20080275475 Schwemberger et al. Nov 2008 A1
20080287737 Dejima Nov 2008 A1
20080287983 Smith et al. Nov 2008 A1
20080300461 Shaw et al. Dec 2008 A1
20080300547 Bakos Dec 2008 A1
20080309758 Karasawa et al. Dec 2008 A1
20080312496 Zwolinski Dec 2008 A1
20080312499 Handa et al. Dec 2008 A1
20080312500 Asada et al. Dec 2008 A1
20080312506 Spivey et al. Dec 2008 A1
20080319436 Daniel et al. Dec 2008 A1
20080319439 Ootsubu Dec 2008 A1
20090054728 Trusty Feb 2009 A1
20090062788 Long et al. Mar 2009 A1
20090062792 Vakharia et al. Mar 2009 A1
20090062795 Vakharia et al. Mar 2009 A1
20090069634 Larkin Mar 2009 A1
20090076499 Azure Mar 2009 A1
20090078736 Van Lue Mar 2009 A1
20090082776 Cresina Mar 2009 A1
20090082779 Nakao Mar 2009 A1
20090112059 Nobis Apr 2009 A1
20090112062 Bakos Apr 2009 A1
20090112063 Bakos et al. Apr 2009 A1
20090125042 Mouw May 2009 A1
20090131751 Spivey et al. May 2009 A1
20090131932 Vakharia et al. May 2009 A1
20090131933 Ghabrial et al. May 2009 A1
20090143639 Stark Jun 2009 A1
20090143649 Rossi Jun 2009 A1
20090143794 Conlon et al. Jun 2009 A1
20090143818 Faller et al. Jun 2009 A1
20090149710 Stefanchik et al. Jun 2009 A1
20090177031 Surti et al. Jul 2009 A1
20090177219 Conlon Jul 2009 A1
20090182332 Long et al. Jul 2009 A1
20090192344 Bakos et al. Jul 2009 A1
20090192534 Ortiz et al. Jul 2009 A1
20090198231 Esser et al. Aug 2009 A1
20090198253 Omori Aug 2009 A1
20090216248 Uenohara et al. Aug 2009 A1
20090248055 Spivey et al. Oct 2009 A1
20090281559 Swain et al. Nov 2009 A1
20090287206 Jun Nov 2009 A1
20090287236 Bakos et al. Nov 2009 A1
20090292164 Yamatani Nov 2009 A1
20090299135 Spivey Dec 2009 A1
20090299143 Conlon et al. Dec 2009 A1
20090299362 Long et al. Dec 2009 A1
20090299385 Stefanchik et al. Dec 2009 A1
20090299406 Swain et al. Dec 2009 A1
20090299409 Coe et al. Dec 2009 A1
20090306658 Nobis et al. Dec 2009 A1
20090306683 Zwolinski et al. Dec 2009 A1
20090322864 Karasawa et al. Dec 2009 A1
20090326561 Carroll, II et al. Dec 2009 A1
20100010294 Conlon et al. Jan 2010 A1
20100010298 Bakos et al. Jan 2010 A1
20100010299 Bakos et al. Jan 2010 A1
20100010303 Bakos Jan 2010 A1
20100010510 Stefanchik Jan 2010 A1
20100010511 Harris et al. Jan 2010 A1
20100023032 Granja Filho Jan 2010 A1
20100036198 Tacchino et al. Feb 2010 A1
20100042045 Spivey Feb 2010 A1
20100048990 Bakos Feb 2010 A1
20100049190 Long et al. Feb 2010 A1
20100049223 Granja Filho Feb 2010 A1
20100056861 Spivey Mar 2010 A1
20100056862 Bakos Mar 2010 A1
20100057085 Holcomb et al. Mar 2010 A1
20100057108 Spivey et al. Mar 2010 A1
20100063538 Spivey et al. Mar 2010 A1
20100076451 Zwolinski et al. Mar 2010 A1
20100081877 Vakharia Apr 2010 A1
20100087813 Long Apr 2010 A1
20100113872 Asada et al. May 2010 A1
20100121362 Clague et al. May 2010 A1
20100130817 Conlon May 2010 A1
20100130975 Long May 2010 A1
20100131005 Conlon May 2010 A1
20100152539 Ghabrial et al. Jun 2010 A1
20100152609 Zwolinski et al. Jun 2010 A1
20100152746 Ceniccola et al. Jun 2010 A1
20100179510 Fox et al. Jul 2010 A1
20100179530 Long et al. Jul 2010 A1
20100191050 Zwolinski Jul 2010 A1
20100191267 Fox Jul 2010 A1
20100198005 Fox Aug 2010 A1
20100198149 Fox Aug 2010 A1
20100198244 Spivey et al. Aug 2010 A1
20100198248 Vakharia Aug 2010 A1
20100249700 Spivey Sep 2010 A1
20100286791 Goldsmith Nov 2010 A1
20100298642 Trusty et al. Nov 2010 A1
20100312056 Galperin et al. Dec 2010 A1
20100331622 Conlon Dec 2010 A2
20100331774 Spivey Dec 2010 A2
20110093009 Fox Apr 2011 A1
20110098694 Long Apr 2011 A1
20110098704 Long et al. Apr 2011 A1
20110105850 Voegele et al. May 2011 A1
20110112434 Ghabrial et al. May 2011 A1
20110115891 Trusty May 2011 A1
20110124964 Nobis May 2011 A1
20110152609 Trusty et al. Jun 2011 A1
20110152610 Trusty et al. Jun 2011 A1
20110152612 Trusty et al. Jun 2011 A1
20110152858 Long et al. Jun 2011 A1
20110152859 Long et al. Jun 2011 A1
20110152878 Trusty et al. Jun 2011 A1
20110152923 Fox Jun 2011 A1
20110160514 Long et al. Jun 2011 A1
20110190659 Long et al. Aug 2011 A1
20110190764 Long et al. Aug 2011 A1
20110245619 Holcomb Oct 2011 A1
20110306971 Long Dec 2011 A1
20120004502 Weitzner et al. Jan 2012 A1
Foreign Referenced Citations (152)
Number Date Country
666310 Feb 1996 AU
3008120 Sep 1980 DE
4323585 Jan 1995 DE
19713797 Oct 1997 DE
19757056 Aug 2008 DE
102006027873 Oct 2009 DE
0086338 Aug 1983 EP
0286415 Oct 1988 EP
0589454 Mar 1994 EP
0464479 Mar 1995 EP
0529675 Feb 1996 EP
0724863 Jul 1999 EP
0760629 Nov 1999 EP
0818974 Jul 2001 EP
1281356 Feb 2003 EP
0947166 May 2003 EP
0836832 Dec 2003 EP
1402837 Mar 2004 EP
0744918 Apr 2004 EP
0931515 Aug 2004 EP
0941128 Oct 2004 EP
1411843 Oct 2004 EP
1150614 Nov 2004 EP
1477104 Nov 2004 EP
1481642 Dec 2004 EP
1493391 Jan 2005 EP
0848598 Feb 2005 EP
1281360 Mar 2005 EP
1568330 Aug 2005 EP
1452143 Sep 2005 EP
1616527 Jan 2006 EP
1006888 Mar 2006 EP
1629764 Mar 2006 EP
1013229 Jun 2006 EP
1721561 Nov 2006 EP
1153578 Mar 2007 EP
1334696 Mar 2007 EP
1769766 Apr 2007 EP
1836971 Sep 2007 EP
1836980 Sep 2007 EP
1854421 Nov 2007 EP
1857061 Nov 2007 EP
1875876 Jan 2008 EP
1891881 Feb 2008 EP
1902663 Mar 2008 EP
1477106 Jun 2008 EP
1949844 Jul 2008 EP
1518499 Aug 2008 EP
1709918 Oct 2008 EP
1985226 Oct 2008 EP
1994904 Nov 2008 EP
1707130 Dec 2008 EP
0723462 Mar 2009 EP
1769749 Nov 2009 EP
1493397 Sep 2011 EP
2731610 Sep 1996 FR
330629 Jun 1930 GB
2335860 Oct 1999 GB
2403909 Jan 2005 GB
2421190 Jun 2006 GB
2443261 Apr 2008 GB
56-46674 Apr 1981 JP
63309252 Dec 1988 JP
4038960 Feb 1992 JP
8-29699 Feb 1996 JP
2000245683 Sep 2000 JP
2002-369791 Dec 2002 JP
2003-088494 Mar 2003 JP
2003-235852 Aug 2003 JP
2004-33525 Feb 2004 JP
2004-065745 Mar 2004 JP
2005-121947 May 2005 JP
2005-261514 Sep 2005 JP
2006297005 Nov 2006 JP
1021295 Feb 2004 NL
194230 May 1967 SU
980703 Dec 1982 SU
WO 8401707 May 1984 WO
WO 9213494 Aug 1992 WO
WO 9310850 Jun 1993 WO
WO 9320760 Oct 1993 WO
WO 9320765 Oct 1993 WO
WO 9509666 Apr 1995 WO
WO 9622056 Jul 1996 WO
WO 9627331 Sep 1996 WO
WO 9639946 Dec 1996 WO
WO 9712557 Apr 1997 WO
WO 9801080 Jan 1998 WO
WO 9900060 Jan 1999 WO
WO 9909919 Mar 1999 WO
WO 9917661 Apr 1999 WO
WO 9930622 Jun 1999 WO
WO 0035358 Jun 2000 WO
WO 0110319 Feb 2001 WO
WO 0126708 Apr 2001 WO
WO 0141627 Jun 2001 WO
WO 0158360 Aug 2001 WO
WO 0211621 Feb 2002 WO
WO 0234122 May 2002 WO
WO 02094082 Nov 2002 WO
WO 03045260 Jun 2003 WO
WO 03047684 Jun 2003 WO
WO 03059412 Jul 2003 WO
WO 03078721 Sep 2003 WO
WO 03081761 Oct 2003 WO
WO 03082129 Oct 2003 WO
WO 2004006789 Jan 2004 WO
WO 2004028613 Apr 2004 WO
WO 2004037123 May 2004 WO
WO 2004037149 May 2004 WO
WO 2004052221 Jun 2004 WO
WO 2004086984 Oct 2004 WO
WO 2005009211 Feb 2005 WO
WO 2005018467 Mar 2005 WO
WO 2005037088 Apr 2005 WO
WO 2005048827 Jun 2005 WO
WO 2005065284 Jul 2005 WO
WO 2005097019 Oct 2005 WO
WO 2005097234 Oct 2005 WO
WO 2005112810 Dec 2005 WO
WO 2005120363 Dec 2005 WO
WO 2006007399 Jan 2006 WO
WO 2006012630 Feb 2006 WO
WO 2006040109 Apr 2006 WO
WO 2006041881 Apr 2006 WO
WO 2006060405 Jun 2006 WO
WO 2006110733 Oct 2006 WO
WO 2006113216 Oct 2006 WO
WO 2007013059 Feb 2007 WO
WO 2007014063 Feb 2007 WO
WO 2007048085 Apr 2007 WO
WO 2007063550 Jun 2007 WO
WO 2007100067 Sep 2007 WO
WO 2007109171 Sep 2007 WO
WO 2008005433 Jan 2008 WO
WO 2008033356 Mar 2008 WO
WO 2008041225 Apr 2008 WO
WO 2008076337 Jun 2008 WO
WO 2008076800 Jun 2008 WO
WO 2008079440 Jul 2008 WO
WO 2008101075 Aug 2008 WO
WO 2008102154 Aug 2008 WO
WO 2008108863 Sep 2008 WO
WO 2008151237 Dec 2008 WO
WO 2009021030 Feb 2009 WO
WO 2009027065 Mar 2009 WO
WO 2009029065 Mar 2009 WO
WO 2009032623 Mar 2009 WO
WO 2009121017 Oct 2009 WO
WO 2010027688 Mar 2010 WO
WO 2010080974 Jul 2010 WO
WO 2010088481 Aug 2010 WO
Related Publications (1)
Number Date Country
20090227828 A1 Sep 2009 US